_MEMBER_SCZ_imp_1 - 94.0-96.0,_MEMBER_SCZ_imp_1 - 96.0-98.0,_MEMBER_SCZ_imp_1 - 98.0-100.0,_LogP_SCZ_imp_1 - 94.0-96.0,_LogP_SCZ_imp_1 - 96.0-98.0,_LogP_SCZ_imp_1 - 98.0-100.0,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,1,1,-2.8,-2.8,-5.3,hsa04662,B cell receptor signaling pathway,M111,3,0
1,1,1,-2.4,-2.4,-2.4,WP2018,RANKL RANK signaling pathway,M111,3,0
1,1,1,-2.3,-2.3,-2.6,GO:0001819,positive regulation of cytokine production,M111,3,0
1,1,1,-2.8,-2.1,-4.6,M183,PID IL6 7 PATHWAY,M111,3,0
1,1,1,-2.5,-2.5,-5.7,WP2849,Hematopoietic stem cell differentiation,M111,3,0
1,1,1,-4.2,-5.1,-2.5,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M111,3,0
1,1,1,-2.6,-5.4,-4.9,GO:0030098,lymphocyte differentiation,M111,3,0
1,1,1,-4.2,-2.1,-2.5,GO:0043010,camera-type eye development,M111,3,0
1,1,1,-4.8,-3,-10,GO:0008283,cell population proliferation,M111,3,0
1,1,1,-2.6,-2.6,-8.2,GO:0051216,cartilage development,M111,3,0
1,1,1,-4.4,-3.2,-4,GO:0070848,response to growth factor,M111,3,0
1,1,1,-3.2,-2.6,-5.3,GO:2000630,positive regulation of miRNA metabolic process,M111,3,0
1,1,1,-2.7,-4.2,-2.7,WP75,Toll like receptor signaling pathway,M111,3,0
1,1,1,-2.3,-5.7,-3.9,hsa04660,T cell receptor signaling pathway,M111,3,0
1,1,1,-3.8,-3.1,-3.8,WP3527,Pre implantation embryo,M111,3,0
1,1,1,-3.2,-2.7,-2.7,GO:0021537,telencephalon development,M111,3,0
1,1,1,-3.8,-2.3,-3,GO:0048880,sensory system development,M111,3,0
1,1,1,-3.9,-2.3,-3,GO:0150063,visual system development,M111,3,0
1,1,1,-3.3,-9.3,-7.2,GO:0045321,leukocyte activation,M111,3,0
1,1,1,-2.4,-2.4,-4,GO:0048701,embryonic cranial skeleton morphogenesis,M111,3,0
1,1,1,-2.4,-2.7,-2,GO:0031344,regulation of cell projection organization,M111,3,0
1,1,1,-2.7,-5.1,-2.7,M235,PID TCR CALCIUM PATHWAY,M111,3,0
1,1,1,-2.7,-3.5,-3.5,GO:1901699,cellular response to nitrogen compound,M111,3,0
1,1,1,-2.1,-2.1,-2.1,WP2840,Hair follicle development cytodifferentiation part 3 of 3,M111,3,0
1,1,1,-2.4,-3.2,-4.9,M7,PID FCER1 PATHWAY,M111,3,0
1,1,1,-3.9,-10,-8.8,GO:0001775,cell activation,M111,3,0
1,1,1,-2.1,-2.1,-4.1,GO:0048704,embryonic skeletal system morphogenesis,M111,3,0
1,1,1,-5,-2.9,-3.3,GO:0071363,cellular response to growth factor stimulus,M111,3,0
1,1,1,-2.6,-3.2,-2,WP4540,Hippo signaling regulation pathways,M111,3,0
1,1,1,-2.9,-2.3,-5.8,GO:1902895,positive regulation of miRNA transcription,M111,3,0
1,1,1,-2.1,-5.6,-6.6,GO:0051249,regulation of lymphocyte activation,M111,3,0
1,1,1,-4,-2.3,-4,GO:0140467,integrated stress response signaling,M111,3,0
1,1,1,-2,-5.1,-3.1,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M111,3,0
1,1,1,-3.4,-2.4,-4,GO:0048839,inner ear development,M111,3,0
1,1,1,-2.4,-2.4,-2.4,GO:0021543,pallium development,M111,3,0
1,1,1,-3.7,-3.7,-7.1,GO:0048562,embryonic organ morphogenesis,M111,3,0
1,1,1,-2.6,-3.8,-3.8,WP366,TGF beta signaling pathway,M111,3,0
1,1,1,-6.1,-2.6,-5.2,GO:0007423,sensory organ development,M111,3,0
1,1,1,-6.7,-5.8,-12,GO:0030097,hemopoiesis,M111,3,0
1,1,1,-2.9,-2.5,-3.4,GO:0021700,developmental maturation,M111,3,0
1,1,1,-3.6,-3.9,-4.7,GO:0071345,cellular response to cytokine stimulus,M111,3,0
1,1,1,-2.6,-2.2,-3,GO:0030900,forebrain development,M111,3,0
1,1,1,-5.1,-2.1,-6.3,hsa05202,Transcriptional misregulation in cancer,M111,3,0
1,1,1,-2.6,-2.6,-2.6,WP4666,Hepatitis B infection,M111,3,0
1,1,1,-2.9,-4.5,-3.7,WP5098,T cell activation SARS CoV 2,M111,3,0
1,1,1,-3.3,-5.1,-3.3,M60,PID NFAT TFPATHWAY,M111,3,0
1,1,1,-4.1,-7.6,-6,GO:0046649,lymphocyte activation,M111,3,0
1,1,1,-2.1,-2.1,-3.6,GO:0071695,anatomical structure maturation,M111,3,0
1,1,1,-3.7,-2.2,-5.4,WP5373,Osteoarthritic chondrocyte hypertrophy,M111,3,0
1,1,1,-2.4,-3,-5,WP3945,TYROBP causal network in microglia,M111,3,0
1,1,1,-2.6,-5.4,-6,GO:0042110,T cell activation,M111,3,0
1,1,1,-3.1,-3.7,-5.8,hsa04380,Osteoclast differentiation,M111,3,0
1,1,1,-2.3,-2.3,-2.3,GO:0042129,regulation of T cell proliferation,M111,3,0
1,1,1,-2.7,-2,-2,WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,M111,3,0
1,1,1,-4,-2.1,-2.4,GO:0001654,eye development,M111,3,0
1,1,1,-2.8,-4.4,-3.5,WP69,T cell receptor signaling pathway,M111,3,0
1,1,1,-3,-2.3,-3.7,GO:1904888,cranial skeletal system development,M111,3,0
1,1,1,-2.1,-2.1,-2.8,GO:0003143,embryonic heart tube morphogenesis,M111,3,0
1,1,1,-2.2,-2.8,-7,GO:0048598,embryonic morphogenesis,M111,3,0
1,1,1,-3.6,-6.7,-6.7,GO:1903131,mononuclear cell differentiation,M111,3,0
1,1,1,-4.8,-4.2,-9.9,GO:0030099,myeloid cell differentiation,M111,3,0
1,1,1,-3.4,-3,-10,GO:0048568,embryonic organ development,M111,3,0
1,1,1,-2.9,-2.3,-2.3,WP4659,Gastrin signaling pathway,M111,3,0
1,1,1,-2.1,-3.1,-3.7,GO:0032946,positive regulation of mononuclear cell proliferation,M111,3,0
1,1,1,-2,-2,-3.3,WP5130,Th17 cell differentiation pathway,M111,3,0
1,1,1,-2.9,-4.9,-6.9,GO:0010720,positive regulation of cell development,M111,3,0
1,1,1,-2.9,-3.4,-7.5,GO:1902105,regulation of leukocyte differentiation,M111,3,0
1,1,1,-2.9,-2.9,-8.9,GO:1903706,regulation of hemopoiesis,M111,3,0
1,1,1,-2.3,-2.3,-2.8,hsa05161,Hepatitis B,M111,3,0
1,1,1,-3.5,-7.4,-8.5,GO:0002521,leukocyte differentiation,M111,3,0
1,1,1,-3.1,-3.1,-3.1,GO:0071417,cellular response to organonitrogen compound,M111,3,0
1,1,1,-2.1,-2.8,-2.1,M285,PID HNF3A PATHWAY,M111,3,0
1,1,1,-2.8,-2.3,-6.1,GO:0140747,regulation of ncRNA transcription,M111,3,0
1,1,1,-2.5,-2.9,-2.9,GO:0071396,cellular response to lipid,M111,3,0
1,1,1,-2.5,-2.5,-2.5,GO:1901653,cellular response to peptide,M111,3,0
1,1,1,-5.4,-2.2,-12,GO:0001501,skeletal system development,M111,3,0
1,1,1,-2.7,-2.1,-2.1,GO:0098727,maintenance of cell number,M111,3,0
1,1,1,-2.6,-4.9,-5.5,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M111,3,0
1,1,1,-2.4,-2.8,-2.1,GO:0120035,regulation of plasma membrane bounded cell projection organization,M111,3,0
1,1,1,-3.3,-2.2,-5.9,GO:2000628,regulation of miRNA metabolic process,M111,3,0
1,1,1,-2.6,-3.2,-2,hsa04928,"Parathyroid hormone synthesis, secretion and action",M111,3,0
1,1,1,-2.1,-4.3,-4.3,GO:0022407,regulation of cell-cell adhesion,M111,3,0
1,0,1,-2.1,0,-5.2,WP5102,Familial partial lipodystrophy,M101,2,0
0,1,1,0,-2.4,-2.4,GO:0050766,positive regulation of phagocytosis,M011,2,0
0,1,1,0,-2.5,-2.5,WP2023,Cell differentiation expanded index,M011,2,0
0,1,1,0,-3.1,-6.1,WP286,IL 3 signaling pathway,M011,2,0
0,1,1,0,-4.3,-5,GO:0002573,myeloid leukocyte differentiation,M011,2,0
1,0,1,-2.6,0,-2.2,GO:0010632,regulation of epithelial cell migration,M101,2,0
0,1,1,0,-2.4,-5.2,M186,PID PDGFRB PATHWAY,M011,2,0
0,1,1,0,-4.4,-7.3,GO:0002683,negative regulation of immune system process,M011,2,0
0,1,1,0,-4.4,-6.6,GO:0051251,positive regulation of lymphocyte activation,M011,2,0
0,1,1,0,-2.7,-3.6,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M011,2,0
1,0,1,-2.8,0,-6.4,GO:0035239,tube morphogenesis,M101,2,0
0,1,1,0,-3.6,-4.8,GO:0050778,positive regulation of immune response,M011,2,0
0,1,1,0,-3,-4,M290,PID IL12 STAT4 PATHWAY,M011,2,0
0,1,1,0,-3.9,-4.6,GO:0050728,negative regulation of inflammatory response,M011,2,0
1,0,1,-2.5,0,-3.6,WP3599,Transcription factor regulation in adipogenesis,M101,2,0
1,0,1,-4.5,0,-4.5,GO:0003151,outflow tract morphogenesis,M101,2,0
1,0,1,-3.7,0,-4.9,GO:0060348,bone development,M101,2,0
1,0,1,-2.6,0,-3.6,GO:0048729,tissue morphogenesis,M101,2,0
0,1,1,0,-2.4,-2.4,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,M011,2,0
0,1,1,0,-3.1,-5.4,GO:0050871,positive regulation of B cell activation,M011,2,0
0,1,1,0,-2.1,-2.1,GO:0051056,regulation of small GTPase mediated signal transduction,M011,2,0
1,0,1,-2.1,0,-3.3,GO:0030111,regulation of Wnt signaling pathway,M101,2,0
0,1,1,0,-2.9,-6.4,GO:0045619,regulation of lymphocyte differentiation,M011,2,0
0,1,1,0,-2.2,-2.2,GO:0002763,positive regulation of myeloid leukocyte differentiation,M011,2,0
0,1,1,0,-2.7,-2.4,GO:0006954,inflammatory response,M011,2,0
0,1,1,0,-2.8,-3.4,GO:0045596,negative regulation of cell differentiation,M011,2,0
1,0,1,-2.4,0,-5,GO:0048706,embryonic skeletal system development,M101,2,0
0,1,1,0,-3.7,-2.7,GO:0002828,regulation of type 2 immune response,M011,2,0
0,1,1,0,-3.5,-2.8,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,M011,2,0
1,0,1,-3.2,0,-3.7,GO:0048736,appendage development,M101,2,0
1,0,1,-2.4,0,-2.9,GO:0060541,respiratory system development,M101,2,0
1,0,1,-2,0,-3,GO:0051146,striated muscle cell differentiation,M101,2,0
0,1,1,0,-2.1,-2.1,GO:0035710,"CD4-positive, alpha-beta T cell activation",M011,2,0
0,1,1,0,-3.8,-3.8,WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,M011,2,0
1,0,1,-2.5,0,-2.5,WP395,IL 4 signaling pathway,M101,2,0
1,1,0,-2.5,-3.9,0,hsa05135,Yersinia infection,M110,2,0
1,0,1,-3.5,0,-3.5,GO:0030326,embryonic limb morphogenesis,M101,2,0
0,1,1,0,-2.9,-3.8,M34,PID TCR PATHWAY,M011,2,0
0,1,1,0,-2.7,-2.4,GO:0045087,innate immune response,M011,2,0
1,1,0,-3.4,-3.4,0,GO:0001779,natural killer cell differentiation,M110,2,0
0,1,1,0,-2.8,-3.3,GO:0002695,negative regulation of leukocyte activation,M011,2,0
1,0,1,-2,0,-4.4,GO:0046645,positive regulation of gamma-delta T cell activation,M101,2,0
0,1,1,0,-2.4,-2.9,GO:0002263,cell activation involved in immune response,M011,2,0
1,1,0,-2.2,-3.3,0,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,M110,2,0
0,1,1,0,-3.2,-5.7,GO:0045580,regulation of T cell differentiation,M011,2,0
1,0,1,-2.2,0,-2.2,GO:0034616,response to laminar fluid shear stress,M101,2,0
0,1,1,0,-3.5,-3.5,GO:0030890,positive regulation of B cell proliferation,M011,2,0
0,1,1,0,-2.1,-2.1,GO:0031295,T cell costimulation,M011,2,0
1,0,1,-3.5,0,-3.5,GO:0035113,embryonic appendage morphogenesis,M101,2,0
0,1,1,0,-3.1,-2.1,GO:0002700,regulation of production of molecular mediator of immune response,M011,2,0
1,1,0,-4.4,-2.9,0,WP2355,Corticotropin releasing hormone signaling pathway,M110,2,0
0,1,1,0,-3.4,-4,GO:0070665,positive regulation of leukocyte proliferation,M011,2,0
1,1,0,-2.2,-2.2,0,R-HSA-448706,Interleukin-1 processing,M110,2,0
1,0,1,-2.7,0,-5.1,GO:0061061,muscle structure development,M101,2,0
1,0,1,-3.3,0,-2.5,GO:0003007,heart morphogenesis,M101,2,0
1,1,0,-2.9,-2.9,0,GO:0010744,positive regulation of macrophage derived foam cell differentiation,M110,2,0
1,1,0,-3.9,-3.3,0,hsa05417,Lipid and atherosclerosis,M110,2,0
1,0,1,-4.4,0,-3,GO:0090596,sensory organ morphogenesis,M101,2,0
1,1,0,-2.7,-2.7,0,hsa04625,C-type lectin receptor signaling pathway,M110,2,0
0,1,1,0,-5.3,-7.6,GO:0050865,regulation of cell activation,M011,2,0
1,0,1,-3.1,0,-3.1,GO:0071499,cellular response to laminar fluid shear stress,M101,2,0
0,1,1,0,-3.3,-2.7,GO:0002702,positive regulation of production of molecular mediator of immune response,M011,2,0
0,1,1,0,-3.8,-7.5,GO:0002696,positive regulation of leukocyte activation,M011,2,0
1,0,1,-5,0,-3,GO:0006351,DNA-templated transcription,M101,2,0
0,1,1,0,-3.8,-2.4,GO:0002703,regulation of leukocyte mediated immunity,M011,2,0
0,1,1,0,-2.6,-4.4,GO:0042063,gliogenesis,M011,2,0
1,0,1,-2.9,0,-6.3,GO:1902893,regulation of miRNA transcription,M101,2,0
0,1,1,0,-2.7,-5.6,GO:1902107,positive regulation of leukocyte differentiation,M011,2,0
0,1,1,0,-2.6,-3.2,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",M011,2,0
0,1,1,0,-2.4,-5.6,GO:0050727,regulation of inflammatory response,M011,2,0
0,1,1,0,-2.5,-4.7,GO:0050777,negative regulation of immune response,M011,2,0
1,0,1,-2.2,0,-5.5,WP4211,Transcriptional cascade regulating adipogenesis,M101,2,0
0,1,1,0,-2.5,-3.3,GO:0001709,cell fate determination,M011,2,0
0,1,1,0,-2.2,-2.2,GO:1903038,negative regulation of leukocyte cell-cell adhesion,M011,2,0
0,1,1,0,-2.3,-2.3,GO:0043368,positive T cell selection,M011,2,0
1,0,1,-3.9,0,-3.4,GO:0060537,muscle tissue development,M101,2,0
1,0,1,-2,0,-3.1,WP3612,Photodynamic therapy induced NFE2L2 NRF2 survival signaling,M101,2,0
1,0,1,-3.1,0,-4.6,GO:0030218,erythrocyte differentiation,M101,2,0
0,1,1,0,-2.8,-3.3,GO:0032944,regulation of mononuclear cell proliferation,M011,2,0
1,0,1,-2.1,0,-2.1,hsa04666,Fc gamma R-mediated phagocytosis,M101,2,0
0,1,1,0,-2.4,-3.1,GO:0032870,cellular response to hormone stimulus,M011,2,0
0,1,1,0,-3.1,-3.1,R-HSA-9658195,Leishmania infection,M011,2,0
1,1,0,-3.5,-2.7,0,GO:0030101,natural killer cell activation,M110,2,0
1,0,1,-3.1,0,-3.8,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,M101,2,0
0,1,1,0,-2.3,-2.9,GO:0048709,oligodendrocyte differentiation,M011,2,0
0,1,1,0,-3.7,-3.7,CORUM:2693,NFAT-JUN-FOS DNA-protein complex,M011,2,0
1,0,1,-3.4,0,-2.1,GO:0007507,heart development,M101,2,0
0,1,1,0,-3.3,-2.2,GO:0060759,regulation of response to cytokine stimulus,M011,2,0
0,1,1,0,-3.9,-2.8,GO:0002819,regulation of adaptive immune response,M011,2,0
1,1,0,-2.7,-2.7,0,M15,PID LYSOPHOSPHOLIPID PATHWAY,M110,2,0
0,1,1,0,-2.7,-2.7,GO:0045061,thymic T cell selection,M011,2,0
0,1,1,0,-2.4,-2.4,M190,PID TCR JNK PATHWAY,M011,2,0
1,0,1,-2,0,-4.6,hsa05200,Pathways in cancer,M101,2,0
1,0,1,-2,0,-4.3,GO:0048469,cell maturation,M101,2,0
0,1,1,0,-2.6,-2.2,GO:0050769,positive regulation of neurogenesis,M011,2,0
0,1,1,0,-2.8,-3.3,GO:0070663,regulation of leukocyte proliferation,M011,2,0
0,1,1,0,-3.7,-2.5,GO:0060627,regulation of vesicle-mediated transport,M011,2,0
1,0,1,-5.5,0,-2.8,GO:0006366,transcription by RNA polymerase II,M101,2,0
1,0,1,-2.4,0,-3.1,hsa05142,Chagas disease,M101,2,0
1,1,0,-2.3,-2.3,0,WP481,Insulin signaling,M110,2,0
0,1,1,0,-3.1,-3.1,GO:0060368,regulation of Fc receptor mediated stimulatory signaling pathway,M011,2,0
0,1,1,0,-2.9,-4.1,GO:0050851,antigen receptor-mediated signaling pathway,M011,2,0
1,0,1,-2.9,0,-3.5,GO:0060349,bone morphogenesis,M101,2,0
0,1,1,0,-2.3,-2.8,GO:0006909,phagocytosis,M011,2,0
1,0,1,-3.1,0,-2,GO:0007519,skeletal muscle tissue development,M101,2,0
1,0,1,-3.3,0,-4.5,GO:0035108,limb morphogenesis,M101,2,0
0,1,1,0,-2.8,-2.2,GO:0002821,positive regulation of adaptive immune response,M011,2,0
0,1,1,0,-4.5,-4.5,GO:0031348,negative regulation of defense response,M011,2,0
1,0,1,-2.3,0,-7.5,GO:0002062,chondrocyte differentiation,M101,2,0
0,1,1,0,-2.5,-4.3,GO:0046634,regulation of alpha-beta T cell activation,M011,2,0
0,1,1,0,-3.1,-4.1,GO:0002429,immune response-activating cell surface receptor signaling pathway,M011,2,0
0,1,1,0,-3.6,-2.3,GO:0019221,cytokine-mediated signaling pathway,M011,2,0
1,0,1,-2.3,0,-2.3,GO:0014902,myotube differentiation,M101,2,0
1,1,0,-2.2,-3.2,0,GO:0009617,response to bacterium,M110,2,0
0,1,1,0,-2,-2,GO:0035051,cardiocyte differentiation,M011,2,0
0,1,1,0,-3,-3,GO:0050866,negative regulation of cell activation,M011,2,0
0,1,1,0,-3.3,-4.1,GO:0030888,regulation of B cell proliferation,M011,2,0
0,1,1,0,-5.6,-5.1,R-HSA-449147,Signaling by Interleukins,M011,2,0
0,1,1,0,-3.4,-5.1,GO:0030217,T cell differentiation,M011,2,0
1,0,1,-4.9,0,-2.9,GO:0032774,RNA biosynthetic process,M101,2,0
0,1,1,0,-2.1,-4,GO:0072189,ureter development,M011,2,0
0,1,1,0,-2.1,-4,GO:0021801,cerebral cortex radial glia-guided migration,M011,2,0
0,1,1,0,-2.2,-3.4,GO:0021780,glial cell fate specification,M011,2,0
0,1,1,0,-3.6,-3.6,WP3892,Development of pulmonary dendritic cells and macrophage subsets,M011,2,0
1,0,1,-2.2,0,-2.9,GO:0090102,cochlea development,M101,2,0
0,1,1,0,-3.1,-2.1,GO:0050900,leukocyte migration,M011,2,0
0,1,1,0,-2.8,-3.6,GO:0032102,negative regulation of response to external stimulus,M011,2,0
1,0,1,-5.1,0,-2.5,WP2374,Oncostatin M signaling pathway,M101,2,0
0,1,1,0,-2.5,-2.1,GO:0001818,negative regulation of cytokine production,M011,2,0
1,1,0,-2.1,-2.1,0,R-HSA-5607764,CLEC7A (Dectin-1) signaling,M110,2,0
0,1,1,0,-2.5,-2.5,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",M011,2,0
1,0,1,-2.1,0,-8.1,GO:0061448,connective tissue development,M101,2,0
1,0,1,-4.9,0,-4.2,GO:0042471,ear morphogenesis,M101,2,0
1,0,1,-3.2,0,-2.7,GO:0007517,muscle organ development,M101,2,0
0,1,1,0,-5.3,-5.3,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M011,2,0
0,1,1,0,-2.1,-2.1,GO:0048534,hematopoietic or lymphoid organ development,M011,2,0
0,1,1,0,-3.3,-3.9,GO:0050671,positive regulation of lymphocyte proliferation,M011,2,0
1,0,1,-2.1,0,-4.8,WP5434,Pathways in cancer,M101,2,0
1,1,0,-2.3,-2.3,0,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,M110,2,0
0,1,1,0,-2.9,-3.4,GO:0050670,regulation of lymphocyte proliferation,M011,2,0
0,1,1,0,-2.1,-4,GO:0022030,telencephalon glial cell migration,M011,2,0
1,0,1,-3.7,0,-3.7,GO:0060021,roof of mouth development,M101,2,0
1,0,1,-2.2,0,-3.2,GO:0090103,cochlea morphogenesis,M101,2,0
1,0,1,-2.9,0,-3.5,R-HSA-9843745,Adipogenesis,M101,2,0
0,1,1,0,-2.3,-2.3,GO:0002699,positive regulation of immune effector process,M011,2,0
0,1,1,0,-2.4,-2.9,GO:0002366,leukocyte activation involved in immune response,M011,2,0
0,1,1,0,-3.2,-6.5,WP2857,Mesodermal commitment pathway,M011,2,0
0,1,1,0,-2.7,-5.6,GO:1903708,positive regulation of hemopoiesis,M011,2,0
0,1,1,0,-3.1,-2.5,WP5224,2q37 copy number variation syndrome,M011,2,0
1,1,0,-2,-2,0,WP4337,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,M110,2,0
1,0,1,-3.2,0,-3.7,GO:0060173,limb development,M101,2,0
1,0,1,-3.7,0,-8.5,WP4149,White fat cell differentiation,M101,2,0
0,1,1,0,-5.6,-8.7,GO:0002694,regulation of leukocyte activation,M011,2,0
0,1,1,0,-2.7,-2,hsa04650,Natural killer cell mediated cytotoxicity,M011,2,0
1,0,1,-4,0,-7,R-HSA-9616222,Transcriptional regulation of granulopoiesis,M101,2,0
0,1,1,0,-2.2,-2.2,GO:0060441,epithelial tube branching involved in lung morphogenesis,M011,2,0
0,1,1,0,-4,-11,GO:0045165,cell fate commitment,M011,2,0
1,1,0,-2.6,-2,0,hsa04668,TNF signaling pathway,M110,2,0
0,1,1,0,-2.9,-4.9,GO:0050870,positive regulation of T cell activation,M011,2,0
1,0,1,-2.3,0,-2.3,WP4816,TGF beta receptor signaling in skeletal dysplasias,M101,2,0
0,1,1,0,-2,-4.3,GO:0046631,alpha-beta T cell activation,M011,2,0
0,1,1,0,-3.5,-2.8,GO:0002886,regulation of myeloid leukocyte mediated immunity,M011,2,0
1,0,1,-3.9,0,-7,GO:0048705,skeletal system morphogenesis,M101,2,0
1,1,0,-2.2,-2.2,0,R-HSA-9031628,NGF-stimulated transcription,M110,2,0
1,1,0,-2.5,-4.4,0,hsa05170,Human immunodeficiency virus 1 infection,M110,2,0
1,1,0,-2.1,-2.1,0,hsa05132,Salmonella infection,M110,2,0
1,1,0,-2.2,-2.2,0,R-HSA-73980,RNA Polymerase III Transcription Termination,M110,2,0
0,1,1,0,-4.1,-2.4,GO:0042113,B cell activation,M011,2,0
1,1,0,-2.7,-2.7,0,R-HSA-3134963,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,M110,2,0
0,1,1,0,-2.7,-4.5,WP5198,Inflammatory bowel disease signaling,M011,2,0
1,0,1,-2.4,0,-3,GO:0002262,myeloid cell homeostasis,M101,2,0
0,1,1,0,-2.7,-5.9,M88,PID CD8 TCR PATHWAY,M011,2,0
1,0,1,-2.9,0,-5.7,GO:0001701,in utero embryonic development,M101,2,0
1,1,0,-2.4,-2.4,0,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,M110,2,0
0,1,1,0,-2.2,-2.9,GO:2000179,positive regulation of neural precursor cell proliferation,M011,2,0
0,1,1,0,-2.9,-3.4,GO:0010001,glial cell differentiation,M011,2,0
1,0,1,-3.8,0,-3.3,GO:0043583,ear development,M101,2,0
1,1,0,-2.7,-2.7,0,M115,PID REG GR PATHWAY,M110,2,0
0,1,1,0,-2.6,-2.6,M236,PID DELTA NP63 PATHWAY,M011,2,0
1,0,1,-2.5,0,-3.3,M272,PID CD8 TCR DOWNSTREAM PATHWAY,M101,2,0
0,1,1,0,-4.6,-5.6,GO:0050863,regulation of T cell activation,M011,2,0
0,1,1,0,-2.4,-3,GO:0009725,response to hormone,M011,2,0
0,1,1,0,-2.4,-4.5,R-HSA-2871796,FCERI mediated MAPK activation,M011,2,0
0,1,1,0,-3.4,-6.9,GO:0050867,positive regulation of cell activation,M011,2,0
0,1,1,0,-2.4,-3.5,GO:0009611,response to wounding,M011,2,0
0,1,1,0,-2.1,-2.1,GO:2000736,regulation of stem cell differentiation,M011,2,0
1,0,1,-2.2,0,-2.6,GO:1901652,response to peptide,M101,2,0
1,0,1,-4.2,0,-5,M167,PID AP1 PATHWAY,M101,2,0
0,1,1,0,-2.6,-2.6,GO:0043300,regulation of leukocyte degranulation,M011,2,0
0,1,1,0,-2.2,-3.4,GO:0002757,immune response-activating signaling pathway,M011,2,0
1,0,1,-2.7,0,-5.9,GO:0045637,regulation of myeloid cell differentiation,M101,2,0
1,0,1,-2,0,-2.6,GO:0021987,cerebral cortex development,M101,2,0
0,1,1,0,-4.9,-5.8,R-HSA-1280215,Cytokine Signaling in Immune system,M011,2,0
1,1,0,-2.6,-4.1,0,hsa04620,Toll-like receptor signaling pathway,M110,2,0
0,1,1,0,-3,-3,GO:0002250,adaptive immune response,M011,2,0
1,1,0,-2.5,-2,0,GO:0060041,retina development in camera-type eye,M110,2,0
0,1,1,0,-2.3,-2.3,GO:0002637,regulation of immunoglobulin production,M011,2,0
1,0,1,-2.2,0,-3.4,hsa04659,Th17 cell differentiation,M101,2,0
0,1,1,0,-2.3,-2.8,GO:0030100,regulation of endocytosis,M011,2,0
0,1,1,0,-2.2,-4.3,GO:0046641,positive regulation of alpha-beta T cell proliferation,M011,2,0
0,1,1,0,-2.5,-2.1,GO:0051962,positive regulation of nervous system development,M011,2,0
0,1,1,0,-4.9,-4.9,GO:0022409,positive regulation of cell-cell adhesion,M011,2,0
0,1,1,0,-2.5,-3.3,GO:0021799,cerebral cortex radially oriented cell migration,M011,2,0
0,1,1,0,-2.1,-5.9,GO:0045621,positive regulation of lymphocyte differentiation,M011,2,0
1,1,0,-3,-2.1,0,WP408,Oxidative stress response,M110,2,0
0,1,1,0,-4.8,-2.2,R-HSA-8951671,RUNX3 regulates YAP1-mediated transcription,M011,2,0
1,0,1,-2.7,0,-6.6,GO:0001944,vasculature development,M101,2,0
0,1,1,0,-3.3,-2,M124,PID CXCR4 PATHWAY,M011,2,0
0,1,1,0,-2.2,-3.4,GO:0002252,immune effector process,M011,2,0
1,0,1,-3.1,0,-5.1,GO:0048514,blood vessel morphogenesis,M101,2,0
0,1,1,0,-3,-6.6,M10,PID BCR 5PATHWAY,M011,2,0
0,1,1,0,-3.1,-3.1,R-HSA-9824443,Parasitic Infection Pathways,M011,2,0
1,0,1,-2.7,0,-3.8,GO:0046643,regulation of gamma-delta T cell activation,M101,2,0
0,1,1,0,-5.6,-5.1,GO:1903037,regulation of leukocyte cell-cell adhesion,M011,2,0
0,1,1,0,-3.1,-5,GO:0050864,regulation of B cell activation,M011,2,0
1,1,0,-3.8,-3.8,0,WP2064,Neural crest differentiation,M110,2,0
0,1,1,0,-2.7,-2.7,GO:2000739,regulation of mesenchymal stem cell differentiation,M011,2,0
1,0,1,-2,0,-2,GO:0055001,muscle cell development,M101,2,0
1,1,0,-2.1,-3.6,0,WP706,Sudden infant death syndrome SIDS susceptibility pathways,M110,2,0
1,0,1,-2.4,0,-7,GO:0045646,regulation of erythrocyte differentiation,M101,2,0
0,1,1,0,-2.7,-2.1,R-HSA-8878159,Transcriptional regulation by RUNX3,M011,2,0
0,1,1,0,-2.7,-2.7,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M011,2,0
0,1,1,0,-2.2,-2.5,GO:0051336,regulation of hydrolase activity,M011,2,0
1,0,1,-2.8,0,-4.3,GO:0034101,erythrocyte homeostasis,M101,2,0
1,0,1,-3.5,0,-5,GO:0042472,inner ear morphogenesis,M101,2,0
0,1,1,0,-2.4,-8.7,WP23,B cell receptor signaling pathway,M011,2,0
1,0,1,-3.3,0,-4.5,GO:0035107,appendage morphogenesis,M101,2,0
0,1,1,0,-2.3,-2.3,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M011,2,0
0,1,1,0,-2.6,-4.8,GO:0007167,enzyme-linked receptor protein signaling pathway,M011,2,0
0,1,1,0,-2.7,-4.9,WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,M011,2,0
0,1,1,0,-2.1,-5.2,hsa04664,Fc epsilon RI signaling pathway,M011,2,0
1,0,1,-2,0,-2,WP3630,NAD metabolism sirtuins and aging,M101,2,0
0,1,1,0,-2.4,-4.1,M8626,SIG BCR SIGNALING PATHWAY,M011,2,0
1,0,1,-2.7,0,-6.8,GO:0050678,regulation of epithelial cell proliferation,M101,2,0
1,0,1,-3.3,0,-3,GO:0007420,brain development,M101,2,0
1,0,1,-2,0,-2,GO:0060872,semicircular canal development,M101,2,0
0,1,1,0,-4.1,-5.5,GO:0045785,positive regulation of cell adhesion,M011,2,0
0,1,1,0,-3.6,-5.2,GO:0050764,regulation of phagocytosis,M011,2,0
1,0,1,-4.9,0,-4,GO:0061515,myeloid cell development,M101,2,0
1,0,1,-2.5,0,-7.9,GO:0043009,chordate embryonic development,M101,2,0
0,1,1,0,-2.5,-2.5,M141,PID PI3KCI PATHWAY,M011,2,0
1,0,1,-2.9,0,-6.9,GO:0001568,blood vessel development,M101,2,0
0,1,1,0,-2.3,-3.8,GO:0050853,B cell receptor signaling pathway,M011,2,0
0,1,1,0,-4.3,-3.7,GO:0002520,immune system development,M011,2,0
0,1,1,0,-6.6,-5.4,WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,M011,2,0
0,1,1,0,-5.1,-2.7,GO:0002697,regulation of immune effector process,M011,2,0
0,1,1,0,-3.1,-2,GO:0002830,positive regulation of type 2 immune response,M011,2,0
1,0,1,-2.7,0,-7.7,GO:0009792,embryo development ending in birth or egg hatching,M101,2,0
1,1,0,-2.4,-2.4,0,R-HSA-975155,MyD88 dependent cascade initiated on endosome,M110,2,0
1,1,0,-2.1,-2.1,0,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",M110,2,0
0,1,1,0,-4.4,-2.7,GO:0002274,myeloid leukocyte activation,M011,2,0
0,1,1,0,-3.9,-3.1,GO:0045058,T cell selection,M011,2,0
1,0,1,-2.8,0,-3.4,GO:0060322,head development,M101,2,0
0,0,1,0,0,-2.4,M44,PID HIF2PATHWAY,M001,1,0
0,0,1,0,0,-2.4,GO:1902106,negative regulation of leukocyte differentiation,M001,1,0
0,1,0,0,-2.6,0,GO:0042327,positive regulation of phosphorylation,M010,1,0
1,0,0,-2,0,0,GO:0086019,cell-cell signaling involved in cardiac conduction,M100,1,0
0,1,0,0,-2.7,0,GO:0050773,regulation of dendrite development,M010,1,0
1,0,0,-2.4,0,0,CORUM:5233,TNF-alpha/NF-kappa B signaling complex 5,M100,1,0
1,0,0,-2.4,0,0,WP195,IL 1 signaling pathway,M100,1,0
0,1,0,0,-2.9,0,GO:0030183,B cell differentiation,M010,1,0
0,1,0,0,-2.7,0,CORUM:3045,hs4 enhancer complex (faster migrating complex),M010,1,0
1,0,0,-2.3,0,0,GO:0071347,cellular response to interleukin-1,M100,1,0
0,0,1,0,0,-2,GO:0051100,negative regulation of binding,M001,1,0
0,0,1,0,0,-2.4,GO:0060425,lung morphogenesis,M001,1,0
0,0,1,0,0,-2.2,R-HSA-109582,Hemostasis,M001,1,0
0,1,0,0,-2.5,0,WP4565,Neural crest cell migration in cancer,M010,1,0
0,0,1,0,0,-2.4,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,M001,1,0
1,0,0,-2.2,0,0,GO:0048486,parasympathetic nervous system development,M100,1,0
0,0,1,0,0,-4.2,GO:0002761,regulation of myeloid leukocyte differentiation,M001,1,0
0,1,0,0,-2.4,0,GO:0042832,defense response to protozoan,M010,1,0
1,0,0,-2.3,0,0,GO:0032655,regulation of interleukin-12 production,M100,1,0
0,1,0,0,-5.1,0,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,M010,1,0
0,0,1,0,0,-2.3,GO:0009952,anterior/posterior pattern specification,M001,1,0
0,1,0,0,-2.9,0,GO:0071773,cellular response to BMP stimulus,M010,1,0
1,0,0,-2.5,0,0,GO:0043536,positive regulation of blood vessel endothelial cell migration,M100,1,0
1,0,0,-2.1,0,0,R-HSA-1296071,Potassium Channels,M100,1,0
1,0,0,-2.5,0,0,WP5113,Antiviral and anti inflammatory effects of Nrf2 on SARS CoV 2 pathway,M100,1,0
0,1,0,0,-3.1,0,GO:0033674,positive regulation of kinase activity,M010,1,0
0,1,0,0,-2.9,0,GO:0050854,regulation of antigen receptor-mediated signaling pathway,M010,1,0
1,0,0,-2.4,0,0,R-HSA-112315,Transmission across Chemical Synapses,M100,1,0
0,0,1,0,0,-2.1,GO:0010035,response to inorganic substance,M001,1,0
0,0,1,0,0,-2.1,WP4262,Breast cancer pathway,M001,1,0
0,1,0,0,-2.9,0,hsa04392,Hippo signaling pathway - multiple species,M010,1,0
1,0,0,-2.4,0,0,GO:0098930,axonal transport,M100,1,0
0,1,0,0,-2.3,0,hsa04725,Cholinergic synapse,M010,1,0
0,0,1,0,0,-2.2,GO:0071375,cellular response to peptide hormone stimulus,M001,1,0
0,0,1,0,0,-2.2,GO:2000147,positive regulation of cell motility,M001,1,0
0,1,0,0,-4,0,GO:0032663,regulation of interleukin-2 production,M010,1,0
0,0,1,0,0,-3.6,GO:0060438,trachea development,M001,1,0
0,0,1,0,0,-2,hsa05231,Choline metabolism in cancer,M001,1,0
1,0,0,-3.1,0,0,WP2637,Interleukin 1 IL 1 structural pathway,M100,1,0
0,0,1,0,0,-3.1,R-HSA-8951430,RUNX3 regulates WNT signaling,M001,1,0
0,0,1,0,0,-2.3,GO:0060562,epithelial tube morphogenesis,M001,1,0
0,1,0,0,-2.7,0,GO:0034204,lipid translocation,M010,1,0
1,0,0,-2.4,0,0,GO:0070301,cellular response to hydrogen peroxide,M100,1,0
0,1,0,0,-2,0,GO:0034114,regulation of heterotypic cell-cell adhesion,M010,1,0
1,0,0,-4.5,0,0,hsa04724,Glutamatergic synapse,M100,1,0
0,0,1,0,0,-2.7,GO:0007368,determination of left/right symmetry,M001,1,0
0,0,1,0,0,-2.1,WP3678,Amplification and expansion of oncogenic pathways as metastatic traits,M001,1,0
1,0,0,-2.8,0,0,GO:0035914,skeletal muscle cell differentiation,M100,1,0
0,1,0,0,-2.1,0,WP5087,Pleural mesothelioma,M010,1,0
0,0,1,0,0,-3.2,GO:0098868,bone growth,M001,1,0
0,0,1,0,0,-2.8,GO:0001704,formation of primary germ layer,M001,1,0
1,0,0,-2.7,0,0,WP5083,Neuroinflammation and glutamatergic signaling,M100,1,0
1,0,0,-2.5,0,0,GO:0009595,detection of biotic stimulus,M100,1,0
0,0,1,0,0,-2.1,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,M001,1,0
0,0,1,0,0,-2.4,R-HSA-525793,Myogenesis,M001,1,0
0,1,0,0,-2.6,0,GO:0097035,regulation of membrane lipid distribution,M010,1,0
0,1,0,0,-2.4,0,GO:0017121,plasma membrane phospholipid scrambling,M010,1,0
0,0,1,0,0,-3.1,GO:0001502,cartilage condensation,M001,1,0
0,0,1,0,0,-4.2,GO:1902170,cellular response to reactive nitrogen species,M001,1,0
0,0,1,0,0,-2.4,GO:0051046,regulation of secretion,M001,1,0
0,1,0,0,-2.1,0,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,M010,1,0
0,1,0,0,-3.1,0,R-HSA-168898,Toll-like Receptor Cascades,M010,1,0
0,0,1,0,0,-2.1,M162,PID RXR VDR PATHWAY,M001,1,0
1,0,0,-2.7,0,0,M164,PID ERBB1 DOWNSTREAM PATHWAY,M100,1,0
0,1,0,0,-2.3,0,GO:0045682,regulation of epidermis development,M010,1,0
0,1,0,0,-2.9,0,GO:0070884,regulation of calcineurin-NFAT signaling cascade,M010,1,0
0,1,0,0,-2.1,0,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,M010,1,0
0,0,1,0,0,-3.2,R-HSA-9674555,Signaling by CSF3 (G-CSF),M001,1,0
0,0,1,0,0,-2.6,R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,M001,1,0
0,1,0,0,-2.2,0,GO:0031076,embryonic camera-type eye development,M010,1,0
0,0,1,0,0,-4,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",M001,1,0
1,0,0,-2.5,0,0,GO:0071356,cellular response to tumor necrosis factor,M100,1,0
0,0,1,0,0,-2.3,GO:0006869,lipid transport,M001,1,0
0,1,0,0,-2.6,0,GO:0008360,regulation of cell shape,M010,1,0
0,0,1,0,0,-2.2,GO:0061180,mammary gland epithelium development,M001,1,0
0,0,1,0,0,-3.2,GO:2000738,positive regulation of stem cell differentiation,M001,1,0
0,1,0,0,-2.3,0,GO:0060760,positive regulation of response to cytokine stimulus,M010,1,0
0,0,1,0,0,-2.2,GO:0002714,positive regulation of B cell mediated immunity,M001,1,0
0,1,0,0,-2.5,0,GO:0045655,regulation of monocyte differentiation,M010,1,0
0,0,1,0,0,-2.5,GO:0042060,wound healing,M001,1,0
0,1,0,0,-2.2,0,GO:0002208,somatic diversification of immunoglobulins involved in immune response,M010,1,0
0,0,1,0,0,-2.1,GO:0010575,positive regulation of vascular endothelial growth factor production,M001,1,0
1,0,0,-6.3,0,0,GO:0007268,chemical synaptic transmission,M100,1,0
0,0,1,0,0,-2.2,WP1991,SRF and miRs in smooth muscle differentiation and proliferation,M001,1,0
1,0,0,-2.1,0,0,WP5426,HDAC6 interactions in the central nervous system,M100,1,0
0,0,1,0,0,-3.8,GO:0032943,mononuclear cell proliferation,M001,1,0
0,0,1,0,0,-2.9,GO:0046638,positive regulation of alpha-beta T cell differentiation,M001,1,0
1,0,0,-2.5,0,0,GO:0062009,secondary palate development,M100,1,0
0,0,1,0,0,-2.9,GO:0007498,mesoderm development,M001,1,0
0,1,0,0,-2.4,0,GO:0034762,regulation of transmembrane transport,M010,1,0
0,0,1,0,0,-2.8,GO:0032868,response to insulin,M001,1,0
1,0,0,-2.3,0,0,GO:0001101,response to acid chemical,M100,1,0
0,0,1,0,0,-3.7,GO:0045577,regulation of B cell differentiation,M001,1,0
0,1,0,0,-2.3,0,GO:0002237,response to molecule of bacterial origin,M010,1,0
0,0,1,0,0,-2.6,GO:0070849,response to epidermal growth factor,M001,1,0
0,0,1,0,0,-2.6,GO:0072006,nephron development,M001,1,0
0,1,0,0,-2.9,0,GO:0030509,BMP signaling pathway,M010,1,0
0,0,1,0,0,-4.2,M28,PID IL4 2PATHWAY,M001,1,0
1,0,0,-2.7,0,0,WP3593,MicroRNA for targeting cancer growth and vascularization in glioblastoma,M100,1,0
0,0,1,0,0,-2.4,GO:0030854,positive regulation of granulocyte differentiation,M001,1,0
0,0,1,0,0,-2.7,R-HSA-210990,PECAM1 interactions,M001,1,0
1,0,0,-3.7,0,0,GO:0030219,megakaryocyte differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0034612,response to tumor necrosis factor,M100,1,0
0,0,1,0,0,-7.2,GO:0072091,regulation of stem cell proliferation,M001,1,0
1,0,0,-3.1,0,0,GO:0035924,cellular response to vascular endothelial growth factor stimulus,M100,1,0
0,0,1,0,0,-2,GO:0030502,negative regulation of bone mineralization,M001,1,0
0,1,0,0,-2.2,0,GO:0002320,lymphoid progenitor cell differentiation,M010,1,0
0,1,0,0,-3.4,0,WP4537,Hippo YAP signaling,M010,1,0
0,0,1,0,0,-2.4,GO:0009799,specification of symmetry,M001,1,0
0,0,1,0,0,-2.1,GO:0030335,positive regulation of cell migration,M001,1,0
0,0,1,0,0,-3.7,GO:0002861,regulation of inflammatory response to antigenic stimulus,M001,1,0
0,0,1,0,0,-2.6,GO:0036075,replacement ossification,M001,1,0
0,0,1,0,0,-2.2,R-HSA-75892,Platelet Adhesion to exposed collagen,M001,1,0
0,1,0,0,-2.9,0,GO:0010743,regulation of macrophage derived foam cell differentiation,M010,1,0
0,0,1,0,0,-2.8,GO:0035272,exocrine system development,M001,1,0
1,0,0,-2.5,0,0,GO:0010594,regulation of endothelial cell migration,M100,1,0
0,0,1,0,0,-2.6,GO:0060972,left/right pattern formation,M001,1,0
1,0,0,-2.9,0,0,GO:0019827,stem cell population maintenance,M100,1,0
1,0,0,-2.6,0,0,hsa05130,Pathogenic Escherichia coli infection,M100,1,0
1,0,0,-2,0,0,hsa01523,Antifolate resistance,M100,1,0
0,1,0,0,-2,0,GO:0097066,response to thyroid hormone,M010,1,0
0,0,1,0,0,-3.1,GO:0060018,astrocyte fate commitment,M001,1,0
1,0,0,-3.5,0,0,GO:0035249,"synaptic transmission, glutamatergic",M100,1,0
0,0,1,0,0,-2.5,GO:1904018,positive regulation of vasculature development,M001,1,0
0,0,1,0,0,-3.2,WP5293,Acute myeloid leukemia,M001,1,0
0,0,1,0,0,-2.1,GO:0002285,lymphocyte activation involved in immune response,M001,1,0
0,1,0,0,-2.2,0,GO:0048368,lateral mesoderm development,M010,1,0
0,0,1,0,0,-3.7,GO:0048844,artery morphogenesis,M001,1,0
0,0,1,0,0,-3,GO:0002764,immune response-regulating signaling pathway,M001,1,0
0,1,0,0,-2.1,0,GO:0042116,macrophage activation,M010,1,0
0,0,1,0,0,-2.4,R-HSA-187037,Signaling by NTRK1 (TRKA),M001,1,0
0,0,1,0,0,-2.2,GO:0002712,regulation of B cell mediated immunity,M001,1,0
1,0,0,-2.4,0,0,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,M100,1,0
0,0,1,0,0,-2.1,GO:0034405,response to fluid shear stress,M001,1,0
0,0,1,0,0,-2.5,GO:0120031,plasma membrane bounded cell projection assembly,M001,1,0
0,0,1,0,0,-2.2,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,M001,1,0
1,0,0,-2.5,0,0,WP4482,Vitamin D in inflammatory diseases,M100,1,0
0,0,1,0,0,-2.7,WP5066,FOXA2 pathway,M001,1,0
0,0,1,0,0,-2.9,GO:0002052,positive regulation of neuroblast proliferation,M001,1,0
0,1,0,0,-2.5,0,GO:0016445,somatic diversification of immunoglobulins,M010,1,0
0,0,1,0,0,-2.4,GO:0048340,paraxial mesoderm morphogenesis,M001,1,0
0,1,0,0,-2.4,0,GO:0014003,oligodendrocyte development,M010,1,0
1,0,0,-2.6,0,0,WP5417,Cell lineage map for neuronal differentiation,M100,1,0
0,0,1,0,0,-4.5,GO:0045600,positive regulation of fat cell differentiation,M001,1,0
0,0,1,0,0,-2.8,GO:0031214,biomineral tissue development,M001,1,0
0,1,0,0,-2.4,0,GO:0043313,regulation of neutrophil degranulation,M010,1,0
0,0,1,0,0,-3.6,GO:0014033,neural crest cell differentiation,M001,1,0
0,0,1,0,0,-2.6,GO:0030879,mammary gland development,M001,1,0
1,0,0,-2.1,0,0,GO:0006897,endocytosis,M100,1,0
0,0,1,0,0,-2.6,GO:0002068,glandular epithelial cell development,M001,1,0
0,0,1,0,0,-2.7,GO:0072001,renal system development,M001,1,0
0,0,1,0,0,-4.6,GO:0045598,regulation of fat cell differentiation,M001,1,0
0,0,1,0,0,-3.3,GO:0051101,regulation of DNA binding,M001,1,0
0,0,1,0,0,-2.9,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M001,1,0
0,1,0,0,-2.1,0,GO:0031341,regulation of cell killing,M010,1,0
1,0,0,-2.3,0,0,hsa04218,Cellular senescence,M100,1,0
0,0,1,0,0,-2,GO:0048865,stem cell fate commitment,M001,1,0
0,1,0,0,-3.6,0,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,M010,1,0
0,1,0,0,-2,0,GO:0043065,positive regulation of apoptotic process,M010,1,0
0,0,1,0,0,-2.8,GO:0048545,response to steroid hormone,M001,1,0
0,0,1,0,0,-2.7,GO:0009100,glycoprotein metabolic process,M001,1,0
1,0,0,-2.2,0,0,hsa04912,GnRH signaling pathway,M100,1,0
1,0,0,-2.3,0,0,GO:0060412,ventricular septum morphogenesis,M100,1,0
0,0,1,0,0,-2.1,GO:0040017,positive regulation of locomotion,M001,1,0
0,0,1,0,0,-2.2,R-HSA-5619507,Activation of HOX genes during differentiation,M001,1,0
0,0,1,0,0,-2.9,GO:0071364,cellular response to epidermal growth factor stimulus,M001,1,0
0,1,0,0,-2.1,0,GO:0002312,B cell activation involved in immune response,M010,1,0
0,0,1,0,0,-2.2,GO:0033630,positive regulation of cell adhesion mediated by integrin,M001,1,0
0,0,1,0,0,-2,GO:0014842,regulation of skeletal muscle satellite cell proliferation,M001,1,0
0,0,1,0,0,-2.2,GO:0048754,branching morphogenesis of an epithelial tube,M001,1,0
0,0,1,0,0,-3.1,WP437,EGF EGFR signaling pathway,M001,1,0
0,0,1,0,0,-2.3,GO:0070542,response to fatty acid,M001,1,0
1,0,0,-2.6,0,0,GO:0034329,cell junction assembly,M100,1,0
1,0,0,-2.3,0,0,GO:0042130,negative regulation of T cell proliferation,M100,1,0
0,0,1,0,0,-4.4,GO:0050680,negative regulation of epithelial cell proliferation,M001,1,0
1,0,0,-2.7,0,0,GO:0035116,embryonic hindlimb morphogenesis,M100,1,0
1,0,0,-2.1,0,0,GO:0032675,regulation of interleukin-6 production,M100,1,0
0,1,0,0,-2.7,0,GO:0050775,positive regulation of dendrite morphogenesis,M010,1,0
0,1,0,0,-2.1,0,hsa04015,Rap1 signaling pathway,M010,1,0
0,0,1,0,0,-3.8,R-HSA-354192,Integrin signaling,M001,1,0
0,1,0,0,-2.4,0,GO:0045657,positive regulation of monocyte differentiation,M010,1,0
0,1,0,0,-2.3,0,hsa05140,Leishmaniasis,M010,1,0
1,0,0,-3.1,0,0,GO:0035235,ionotropic glutamate receptor signaling pathway,M100,1,0
0,0,1,0,0,-2.1,R-HSA-166520,Signaling by NTRKs,M001,1,0
0,0,1,0,0,-3.4,GO:0048872,homeostasis of number of cells,M001,1,0
0,0,1,0,0,-2,GO:0018904,ether metabolic process,M001,1,0
1,0,0,-2,0,0,WP4141,PI3K AKT mTOR vitamin D3 signaling,M100,1,0
0,1,0,0,-2.9,0,WP5090,Complement system in neuronal development and plasticity,M010,1,0
1,0,0,-2.4,0,0,GO:2000106,regulation of leukocyte apoptotic process,M100,1,0
1,0,0,-2.4,0,0,hsa04750,Inflammatory mediator regulation of TRP channels,M100,1,0
0,0,1,0,0,-2.5,WP5385,Growth factors and hormones in beta cell proliferation,M001,1,0
0,1,0,0,-3.1,0,hsa04514,Cell adhesion molecules,M010,1,0
0,0,1,0,0,-3.5,R-HSA-76002,"Platelet activation, signaling and aggregation",M001,1,0
0,0,1,0,0,-2.5,GO:0008285,negative regulation of cell population proliferation,M001,1,0
0,1,0,0,-2.9,0,GO:0045332,phospholipid translocation,M010,1,0
0,0,1,0,0,-2.4,GO:0045666,positive regulation of neuron differentiation,M001,1,0
0,0,1,0,0,-2.3,GO:0051963,regulation of synapse assembly,M001,1,0
0,0,1,0,0,-2.1,GO:0046632,alpha-beta T cell differentiation,M001,1,0
0,0,1,0,0,-3.1,hsa04658,Th1 and Th2 cell differentiation,M001,1,0
0,0,1,0,0,-2.2,GO:0003208,cardiac ventricle morphogenesis,M001,1,0
1,0,0,-2.4,0,0,GO:0035855,megakaryocyte development,M100,1,0
0,0,1,0,0,-2.3,GO:0034341,response to type II interferon,M001,1,0
0,0,1,0,0,-2.5,R-HSA-2871809,FCERI mediated Ca+2 mobilization,M001,1,0
0,1,0,0,-2.7,0,WP516,Hypertrophy model,M010,1,0
0,1,0,0,-2.6,0,GO:0045616,regulation of keratinocyte differentiation,M010,1,0
0,0,1,0,0,-2.9,GO:0045765,regulation of angiogenesis,M001,1,0
1,0,0,-2.4,0,0,WP4357,NRF2 ARE regulation,M100,1,0
0,1,0,0,-2.5,0,GO:0010562,positive regulation of phosphorus metabolic process,M010,1,0
0,0,1,0,0,-2.7,R-HSA-389356,CD28 co-stimulation,M001,1,0
0,1,0,0,-2.6,0,GO:0032496,response to lipopolysaccharide,M010,1,0
0,0,1,0,0,-4.3,GO:0046635,positive regulation of alpha-beta T cell activation,M001,1,0
0,0,1,0,0,-3.2,hsa05215,Prostate cancer,M001,1,0
0,0,1,0,0,-2.4,GO:0008347,glial cell migration,M001,1,0
1,0,0,-2.3,0,0,R-HSA-9707616,Heme signaling,M100,1,0
0,1,0,0,-2.1,0,WP4880,Host pathogen interaction of human coronaviruses interferon induction,M010,1,0
0,0,1,0,0,-3.9,GO:0032330,regulation of chondrocyte differentiation,M001,1,0
0,0,1,0,0,-2,R-HSA-4641265,Repression of WNT target genes,M001,1,0
0,0,1,0,0,-2.4,GO:0060509,type I pneumocyte differentiation,M001,1,0
0,0,1,0,0,-2.2,GO:0001822,kidney development,M001,1,0
0,0,1,0,0,-2.2,GO:0002891,positive regulation of immunoglobulin mediated immune response,M001,1,0
1,0,0,-2.2,0,0,GO:0034350,regulation of glial cell apoptotic process,M100,1,0
0,1,0,0,-2.3,0,GO:0002718,regulation of cytokine production involved in immune response,M010,1,0
0,0,1,0,0,-4.8,GO:0045588,positive regulation of gamma-delta T cell differentiation,M001,1,0
0,0,1,0,0,-2.4,GO:0008286,insulin receptor signaling pathway,M001,1,0
0,1,0,0,-2.2,0,GO:0002720,positive regulation of cytokine production involved in immune response,M010,1,0
0,0,1,0,0,-3.6,GO:0001763,morphogenesis of a branching structure,M001,1,0
0,0,1,0,0,-2.5,GO:0030852,regulation of granulocyte differentiation,M001,1,0
0,0,1,0,0,-2.3,GO:0046620,regulation of organ growth,M001,1,0
1,0,0,-2.8,0,0,hsa04024,cAMP signaling pathway,M100,1,0
1,0,0,-3.5,0,0,GO:0060538,skeletal muscle organ development,M100,1,0
0,1,0,0,-3.4,0,GO:0035329,hippo signaling,M010,1,0
0,0,1,0,0,-2.4,GO:0034393,positive regulation of smooth muscle cell apoptotic process,M001,1,0
0,0,1,0,0,-3.1,GO:0071732,cellular response to nitric oxide,M001,1,0
1,0,0,-5.9,0,0,GO:0099537,trans-synaptic signaling,M100,1,0
0,0,1,0,0,-2.2,GO:0070344,regulation of fat cell proliferation,M001,1,0
0,0,1,0,0,-2.2,R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,M001,1,0
0,1,0,0,-3.1,0,R-HSA-5621481,C-type lectin receptors (CLRs),M010,1,0
0,0,1,0,0,-2.4,GO:0072163,mesonephric epithelium development,M001,1,0
0,0,1,0,0,-2.2,GO:0046629,gamma-delta T cell activation,M001,1,0
0,1,0,0,-3.2,0,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M010,1,0
1,0,0,-2.7,0,0,WP5192,Modulation of PI3K Akt mTOR signaling by bioactive sphingolipids,M100,1,0
0,0,1,0,0,-4.7,GO:0010464,regulation of mesenchymal cell proliferation,M001,1,0
0,0,1,0,0,-3.5,GO:0045648,positive regulation of erythrocyte differentiation,M001,1,0
1,0,0,-2.1,0,0,WP2884,NRF2 pathway,M100,1,0
0,1,0,0,-2.1,0,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,M010,1,0
0,0,1,0,0,-3.2,M255,PID HIF1 TFPATHWAY,M001,1,0
1,0,0,-2.3,0,0,GO:0030833,regulation of actin filament polymerization,M100,1,0
0,0,1,0,0,-4.4,GO:0060350,endochondral bone morphogenesis,M001,1,0
0,1,0,0,-2,0,R-HSA-9013423,RAC3 GTPase cycle,M010,1,0
0,0,1,0,0,-2.7,WP4808,Endochondral ossification with skeletal dysplasias,M001,1,0
0,0,1,0,0,-2.5,R-HSA-9006335,Signaling by Erythropoietin,M001,1,0
0,0,1,0,0,-3.4,GO:0061138,morphogenesis of a branching epithelium,M001,1,0
0,0,1,0,0,-3,hsa05226,Gastric cancer,M001,1,0
1,0,0,-6.3,0,0,GO:0098916,anterograde trans-synaptic signaling,M100,1,0
0,0,1,0,0,-4.2,GO:0032808,lacrimal gland development,M001,1,0
0,0,1,0,0,-2.7,GO:0042102,positive regulation of T cell proliferation,M001,1,0
0,0,1,0,0,-2.7,GO:0048866,stem cell fate specification,M001,1,0
0,0,1,0,0,-2.1,GO:0030522,intracellular receptor signaling pathway,M001,1,0
0,0,1,0,0,-2.7,GO:0048871,multicellular organismal-level homeostasis,M001,1,0
0,0,1,0,0,-2.8,GO:2000177,regulation of neural precursor cell proliferation,M001,1,0
0,0,1,0,0,-2.9,GO:0045579,positive regulation of B cell differentiation,M001,1,0
0,1,0,0,-2.4,0,R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,M010,1,0
1,0,0,-2.3,0,0,GO:0034599,cellular response to oxidative stress,M100,1,0
1,0,0,-2.5,0,0,GO:0098581,detection of external biotic stimulus,M100,1,0
0,1,0,0,-3.7,0,WP4534,Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms,M010,1,0
1,0,0,-2.3,0,0,GO:0071229,cellular response to acid chemical,M100,1,0
0,1,0,0,-2.8,0,WP4217,Ebola virus infection in host,M010,1,0
0,1,0,0,-3.3,0,WP3929,Chemokine signaling pathway,M010,1,0
0,1,0,0,-2.7,0,M175,PID ERBB2 ERBB3 PATHWAY,M010,1,0
0,1,0,0,-2.7,0,GO:0042092,type 2 immune response,M010,1,0
0,1,0,0,-2.6,0,GO:0045622,regulation of T-helper cell differentiation,M010,1,0
0,0,1,0,0,-2.7,GO:0071731,response to nitric oxide,M001,1,0
0,0,1,0,0,-2.4,GO:1903305,regulation of regulated secretory pathway,M001,1,0
1,0,0,-2.4,0,0,GO:0030166,proteoglycan biosynthetic process,M100,1,0
0,0,1,0,0,-2.3,GO:0001656,metanephros development,M001,1,0
0,0,1,0,0,-3.2,GO:0007405,neuroblast proliferation,M001,1,0
0,1,0,0,-2.2,0,R-HSA-3214841,PKMTs methylate histone lysines,M010,1,0
1,0,0,-3.8,0,0,hsa04657,IL-17 signaling pathway,M100,1,0
0,0,1,0,0,-3.1,R-HSA-983705,Signaling by the B Cell Receptor (BCR),M001,1,0
0,0,1,0,0,-5.4,WP4844,Influence of laminopathies on Wnt signaling,M001,1,0
0,0,1,0,0,-4.9,GO:0048863,stem cell differentiation,M001,1,0
0,0,1,0,0,-2.5,GO:0001937,negative regulation of endothelial cell proliferation,M001,1,0
0,0,1,0,0,-2.4,GO:0050873,brown fat cell differentiation,M001,1,0
1,0,0,-2.7,0,0,WP3,Transcriptional activation by NRF2 in response to phytochemicals,M100,1,0
0,0,1,0,0,-2.7,GO:0045060,negative thymic T cell selection,M001,1,0
0,1,0,0,-2.8,0,GO:0019722,calcium-mediated signaling,M010,1,0
0,0,1,0,0,-2.2,GO:1901524,regulation of mitophagy,M001,1,0
0,0,1,0,0,-2,GO:0043301,negative regulation of leukocyte degranulation,M001,1,0
0,1,0,0,-2.4,0,GO:0001959,regulation of cytokine-mediated signaling pathway,M010,1,0
1,0,0,-2.6,0,0,GO:0035909,aorta morphogenesis,M100,1,0
0,0,1,0,0,-2.1,GO:0045766,positive regulation of angiogenesis,M001,1,0
0,1,0,0,-4.1,0,M166,PID ATF2 PATHWAY,M010,1,0
0,1,0,0,-4.3,0,GO:0032507,maintenance of protein location in cell,M010,1,0
0,0,1,0,0,-2.2,GO:0045665,negative regulation of neuron differentiation,M001,1,0
0,0,1,0,0,-3,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,M001,1,0
0,0,1,0,0,-2.5,WP4719,Eicosanoid metabolism via cyclooxygenases COX,M001,1,0
0,1,0,0,-2.3,0,GO:0045604,regulation of epidermal cell differentiation,M010,1,0
0,0,1,0,0,-2.7,R-HSA-9027284,Erythropoietin activates RAS,M001,1,0
0,0,1,0,0,-3.9,GO:0045664,regulation of neuron differentiation,M001,1,0
1,0,0,-2.1,0,0,GO:1900077,negative regulation of cellular response to insulin stimulus,M100,1,0
0,0,1,0,0,-2.2,R-HSA-4090294,SUMOylation of intracellular receptors,M001,1,0
0,1,0,0,-2.1,0,WP4559,Interactions between immune cells and microRNAs in tumor microenvironment,M010,1,0
1,0,0,-2.4,0,0,GO:0060078,regulation of postsynaptic membrane potential,M100,1,0
0,0,1,0,0,-3.4,R-HSA-4411364,Binding of TCF/LEF:CTNNB1 to target gene promoters,M001,1,0
0,0,1,0,0,-2.4,GO:0046847,filopodium assembly,M001,1,0
0,0,1,0,0,-2.4,GO:0045059,positive thymic T cell selection,M001,1,0
0,0,1,0,0,-3.7,GO:2000741,positive regulation of mesenchymal stem cell differentiation,M001,1,0
0,1,0,0,-3.5,0,GO:0032743,positive regulation of interleukin-2 production,M010,1,0
0,0,1,0,0,-3.6,GO:0072132,mesenchyme morphogenesis,M001,1,0
1,0,0,-2.7,0,0,GO:0086066,atrial cardiac muscle cell to AV node cell communication,M100,1,0
1,0,0,-2.7,0,0,GO:0086014,atrial cardiac muscle cell action potential,M100,1,0
0,1,0,0,-2.1,0,WP3967,miR 509 3p alteration of YAP1 ECM axis,M010,1,0
0,0,1,0,0,-2.7,GO:0051098,regulation of binding,M001,1,0
0,0,1,0,0,-2.7,GO:0015908,fatty acid transport,M001,1,0
0,1,0,0,-2.1,0,R-HSA-8941326,RUNX2 regulates bone development,M010,1,0
0,0,1,0,0,-2.6,WP1541,Energy metabolism,M001,1,0
0,1,0,0,-3,0,hsa04062,Chemokine signaling pathway,M010,1,0
0,0,1,0,0,-2.2,GO:0002889,regulation of immunoglobulin mediated immune response,M001,1,0
0,0,1,0,0,-3.7,CORUM:2695,ETS2-FOS-JUN complex,M001,1,0
0,0,1,0,0,-2,GO:0060576,intestinal epithelial cell development,M001,1,0
0,0,1,0,0,-3.4,WP313,Hepatocyte growth factor receptor signaling,M001,1,0
0,0,1,0,0,-3.1,GO:0003417,growth plate cartilage development,M001,1,0
0,0,1,0,0,-2.4,GO:0002443,leukocyte mediated immunity,M001,1,0
0,0,1,0,0,-6.3,GO:0061351,neural precursor cell proliferation,M001,1,0
0,0,1,0,0,-2.9,GO:0002067,glandular epithelial cell differentiation,M001,1,0
0,0,1,0,0,-4.4,GO:0040007,growth,M001,1,0
0,1,0,0,-2.1,0,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,M010,1,0
1,0,0,-3.1,0,0,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,M100,1,0
0,0,1,0,0,-2.2,GO:0010921,regulation of phosphatase activity,M001,1,0
1,0,0,-2.7,0,0,WP5395,Glycosaminoglycan synthesis in fibroblasts,M100,1,0
0,0,1,0,0,-2.4,GO:0048732,gland development,M001,1,0
0,0,1,0,0,-4.6,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,M001,1,0
1,0,0,-2,0,0,GO:2001198,regulation of dendritic cell differentiation,M100,1,0
1,0,0,-2.3,0,0,GO:0007605,sensory perception of sound,M100,1,0
0,0,1,0,0,-2.4,GO:0009855,determination of bilateral symmetry,M001,1,0
0,1,0,0,-2.4,0,GO:0021892,cerebral cortex GABAergic interneuron differentiation,M010,1,0
1,0,0,-6.1,0,0,GO:0099536,synaptic signaling,M100,1,0
0,0,1,0,0,-3.4,GO:0002066,columnar/cuboidal epithelial cell development,M001,1,0
1,0,0,-2.3,0,0,WP410,Exercise induced circadian regulation,M100,1,0
0,0,1,0,0,-4.3,GO:2000648,positive regulation of stem cell proliferation,M001,1,0
0,0,1,0,0,-3,GO:0045662,negative regulation of myoblast differentiation,M001,1,0
1,0,0,-2.6,0,0,GO:0035137,hindlimb morphogenesis,M100,1,0
0,1,0,0,-3.1,0,GO:0010912,positive regulation of isomerase activity,M010,1,0
0,0,1,0,0,-2.7,GO:0043378,"positive regulation of CD8-positive, alpha-beta T cell differentiation",M001,1,0
1,0,0,-3,0,0,GO:0038084,vascular endothelial growth factor signaling pathway,M100,1,0
0,0,1,0,0,-2.7,GO:1902692,regulation of neuroblast proliferation,M001,1,0
0,0,1,0,0,-2.5,GO:0043392,negative regulation of DNA binding,M001,1,0
1,0,0,-2.1,0,0,GO:1990089,response to nerve growth factor,M100,1,0
0,0,1,0,0,-2.5,GO:1903530,regulation of secretion by cell,M001,1,0
1,0,0,-3.2,0,0,WP4754,IL 18 signaling pathway,M100,1,0
0,1,0,0,-2,0,GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,M010,1,0
0,0,1,0,0,-2.8,WP170,Nuclear receptors,M001,1,0
0,0,1,0,0,-2.5,R-HSA-9664407,Parasite infection,M001,1,0
0,1,0,0,-3.3,0,GO:0060395,SMAD protein signal transduction,M010,1,0
1,0,0,-3.4,0,0,WP4871,Kisspeptin kisspeptin receptor system in the ovary,M100,1,0
0,0,1,0,0,-2.4,GO:0072164,mesonephric tubule development,M001,1,0
0,0,1,0,0,-2.2,GO:0043376,"regulation of CD8-positive, alpha-beta T cell differentiation",M001,1,0
0,0,1,0,0,-3.3,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M001,1,0
0,0,1,0,0,-3,WP363,Wnt signaling pathway,M001,1,0
0,0,1,0,0,-3,GO:0002009,morphogenesis of an epithelium,M001,1,0
0,0,1,0,0,-2.4,WP4950,16p11 2 distal deletion syndrome,M001,1,0
1,0,0,-3.2,0,0,GO:0050808,synapse organization,M100,1,0
0,0,1,0,0,-2.2,GO:0071407,cellular response to organic cyclic compound,M001,1,0
0,0,1,0,0,-3.2,M22,PID GMCSF PATHWAY,M001,1,0
0,0,1,0,0,-2.7,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,M001,1,0
0,1,0,0,-2,0,GO:0014013,regulation of gliogenesis,M010,1,0
0,0,1,0,0,-3.3,R-HSA-1280218,Adaptive Immune System,M001,1,0
0,0,1,0,0,-2.4,GO:0015732,prostaglandin transport,M001,1,0
0,0,1,0,0,-2,GO:0071453,cellular response to oxygen levels,M001,1,0
1,0,0,-2.1,0,0,hsa05131,Shigellosis,M100,1,0
0,0,1,0,0,-3.7,GO:0051345,positive regulation of hydrolase activity,M001,1,0
0,1,0,0,-2.3,0,GO:0043068,positive regulation of programmed cell death,M010,1,0
0,1,0,0,-2.5,0,WP4564,Neural crest cell migration during development,M010,1,0
0,0,1,0,0,-3.8,GO:0046651,lymphocyte proliferation,M001,1,0
0,0,1,0,0,-2.5,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,M001,1,0
0,1,0,0,-2.7,0,M159,PID AMB2 NEUTROPHILS PATHWAY,M010,1,0
0,0,1,0,0,-3.3,GO:0030282,bone mineralization,M001,1,0
0,0,1,0,0,-2.4,GO:0001657,ureteric bud development,M001,1,0
1,0,0,-2.4,0,0,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,M100,1,0
0,0,1,0,0,-3.1,GO:1901503,ether biosynthetic process,M001,1,0
1,0,0,-2.3,0,0,GO:0035904,aorta development,M100,1,0
0,0,1,0,0,-3.2,GO:1901342,regulation of vasculature development,M001,1,0
0,0,1,0,0,-3.4,R-HSA-2424491,DAP12 signaling,M001,1,0
0,0,1,0,0,-3.6,GO:0048762,mesenchymal cell differentiation,M001,1,0
0,0,1,0,0,-2.3,GO:0051145,smooth muscle cell differentiation,M001,1,0
0,1,0,0,-2,0,GO:0060326,cell chemotaxis,M010,1,0
1,0,0,-2.3,0,0,GO:0051592,response to calcium ion,M100,1,0
0,1,0,0,-3.1,0,hsa04960,Aldosterone-regulated sodium reabsorption,M010,1,0
0,0,1,0,0,-2.4,GO:0003205,cardiac chamber development,M001,1,0
0,1,0,0,-2.6,0,GO:0051960,regulation of nervous system development,M010,1,0
0,1,0,0,-3,0,GO:0048596,embryonic camera-type eye morphogenesis,M010,1,0
0,0,1,0,0,-2.6,GO:0071560,cellular response to transforming growth factor beta stimulus,M001,1,0
1,0,0,-2.7,0,0,GO:0072537,fibroblast activation,M100,1,0
0,0,1,0,0,-2.9,M206,PID PDGFRA PATHWAY,M001,1,0
1,0,0,-2.5,0,0,GO:0042391,regulation of membrane potential,M100,1,0
0,0,1,0,0,-2.5,GO:0007389,pattern specification process,M001,1,0
1,0,0,-2.8,0,0,GO:0048857,neural nucleus development,M100,1,0
0,1,0,0,-2.1,0,GO:0006898,receptor-mediated endocytosis,M010,1,0
0,1,0,0,-2.2,0,WP4533,Transcription co factors SKI and SKIL protein partners,M010,1,0
0,1,0,0,-2,0,R-HSA-6803157,Antimicrobial peptides,M010,1,0
0,1,0,0,-2,0,GO:1904893,negative regulation of receptor signaling pathway via STAT,M010,1,0
0,0,1,0,0,-2.7,hsa05211,Renal cell carcinoma,M001,1,0
1,0,0,-3.3,0,0,WP3888,VEGFA VEGFR2 signaling,M100,1,0
1,0,0,-2.7,0,0,hsa04613,Neutrophil extracellular trap formation,M100,1,0
0,1,0,0,-2.2,0,WP4630,Measles virus infection,M010,1,0
0,0,1,0,0,-3.3,WP4216,Chromosomal and microsatellite instability in colorectal cancer,M001,1,0
0,0,1,0,0,-4.9,GO:0001503,ossification,M001,1,0
0,0,1,0,0,-2.5,GO:0010721,negative regulation of cell development,M001,1,0
0,0,1,0,0,-2.1,WP127,IL 5 signaling pathway,M001,1,0
0,1,0,0,-2,0,WP5142,Calcium mediated T cell apoptosis involved in inclusion body myositis,M010,1,0
0,1,0,0,-2.2,0,GO:0051090,regulation of DNA-binding transcription factor activity,M010,1,0
0,0,1,0,0,-2.7,R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,M001,1,0
0,0,1,0,0,-2.7,GO:0002065,columnar/cuboidal epithelial cell differentiation,M001,1,0
0,1,0,0,-2.2,0,GO:0048483,autonomic nervous system development,M010,1,0
0,0,1,0,0,-4,GO:0060840,artery development,M001,1,0
1,0,0,-2.2,0,0,R-HSA-9818749,Regulation of NFE2L2 gene expression,M100,1,0
0,1,0,0,-2.8,0,GO:0051347,positive regulation of transferase activity,M010,1,0
0,1,0,0,-2.7,0,GO:0010770,positive regulation of cell morphogenesis,M010,1,0
0,0,1,0,0,-2.2,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,M001,1,0
0,0,1,0,0,-2,WP167,Eicosanoid synthesis,M001,1,0
1,0,0,-2.7,0,0,GO:0035115,embryonic forelimb morphogenesis,M100,1,0
1,0,0,-2.5,0,0,GO:0071634,regulation of transforming growth factor beta production,M100,1,0
0,0,1,0,0,-2.6,GO:0032869,cellular response to insulin stimulus,M001,1,0
0,0,1,0,0,-2.7,R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins,M001,1,0
0,0,1,0,0,-2.2,GO:0006691,leukotriene metabolic process,M001,1,0
0,0,1,0,0,-3.9,GO:0001890,placenta development,M001,1,0
1,0,0,-2.1,0,0,GO:0060252,positive regulation of glial cell proliferation,M100,1,0
1,0,0,-2.9,0,0,WP382,MAPK signaling pathway,M100,1,0
0,0,1,0,0,-2.4,GO:0043087,regulation of GTPase activity,M001,1,0
0,0,1,0,0,-2.1,GO:0032332,positive regulation of chondrocyte differentiation,M001,1,0
1,0,0,-2.7,0,0,M143,PID IL2 PI3K PATHWAY,M100,1,0
0,1,0,0,-2.2,0,GO:0045605,negative regulation of epidermal cell differentiation,M010,1,0
0,0,1,0,0,-4.5,GO:0060485,mesenchyme development,M001,1,0
0,0,1,0,0,-3.5,GO:0001525,angiogenesis,M001,1,0
0,1,0,0,-2.9,0,GO:0106056,regulation of calcineurin-mediated signaling,M010,1,0
0,1,0,0,-2.3,0,GO:0007159,leukocyte cell-cell adhesion,M010,1,0
0,0,1,0,0,-6.7,WP236,Adipogenesis,M001,1,0
0,0,1,0,0,-2.5,GO:0003002,regionalization,M001,1,0
1,0,0,-2.9,0,0,GO:0051489,regulation of filopodium assembly,M100,1,0
1,0,0,-2.2,0,0,GO:0002357,defense response to tumor cell,M100,1,0
0,0,1,0,0,-2.7,WP474,Endochondral ossification,M001,1,0
0,0,1,0,0,-2.9,GO:0002070,epithelial cell maturation,M001,1,0
0,0,1,0,0,-2.3,WP3646,Hepatitis C and hepatocellular carcinoma,M001,1,0
0,0,1,0,0,-2.1,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",M001,1,0
0,0,1,0,0,-2.6,WP5072,Modulators of TCR signaling and T cell activation,M001,1,0
0,1,0,0,-2.2,0,GO:0150076,neuroinflammatory response,M010,1,0
1,0,0,-2.1,0,0,GO:0001889,liver development,M100,1,0
0,0,1,0,0,-2,GO:0043031,negative regulation of macrophage activation,M001,1,0
0,0,1,0,0,-2.6,GO:0001958,endochondral ossification,M001,1,0
1,0,0,-2.5,0,0,GO:0043535,regulation of blood vessel endothelial cell migration,M100,1,0
1,0,0,-2.2,0,0,hsa04270,Vascular smooth muscle contraction,M100,1,0
1,0,0,-2.2,0,0,GO:1990090,cellular response to nerve growth factor stimulus,M100,1,0
0,0,1,0,0,-4.5,GO:0045639,positive regulation of myeloid cell differentiation,M001,1,0
0,0,1,0,0,-4.3,M17200,SA B CELL RECEPTOR COMPLEXES,M001,1,0
0,0,1,0,0,-3.4,R-HSA-76009,Platelet Aggregation (Plug Formation),M001,1,0
0,0,1,0,0,-2.9,GO:0046456,icosanoid biosynthetic process,M001,1,0
0,0,1,0,0,-2.7,GO:1905563,negative regulation of vascular endothelial cell proliferation,M001,1,0
0,0,1,0,0,-2.1,GO:0072273,metanephric nephron morphogenesis,M001,1,0
0,0,1,0,0,-2,GO:0097529,myeloid leukocyte migration,M001,1,0
1,0,0,-2,0,0,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,M100,1,0
0,1,0,0,-2.2,0,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,M010,1,0
1,0,0,-2,0,0,GO:0032970,regulation of actin filament-based process,M100,1,0
0,0,1,0,0,-4.5,GO:0021781,glial cell fate commitment,M001,1,0
0,0,1,0,0,-3.3,GO:0043547,positive regulation of GTPase activity,M001,1,0
1,0,0,-2.9,0,0,WP4481,Resistin as a regulator of inflammation,M100,1,0
0,0,1,0,0,-4.4,GO:0002064,epithelial cell development,M001,1,0
1,0,0,-2.5,0,0,hsa04926,Relaxin signaling pathway,M100,1,0
0,0,1,0,0,-3.1,GO:0098743,cell aggregation,M001,1,0
0,0,1,0,0,-2.9,GO:1903707,negative regulation of hemopoiesis,M001,1,0
0,0,1,0,0,-3.9,GO:0001708,cell fate specification,M001,1,0
0,1,0,0,-3.7,0,WP4541,Hippo Merlin signaling dysregulation,M010,1,0
0,0,1,0,0,-2.4,WP560,TGF beta receptor signaling,M001,1,0
0,0,1,0,0,-3.5,GO:0021795,cerebral cortex cell migration,M001,1,0
0,0,1,0,0,-4,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,M001,1,0
0,0,1,0,0,-2.1,GO:0060575,intestinal epithelial cell differentiation,M001,1,0
1,0,0,-2.2,0,0,GO:0007216,G protein-coupled glutamate receptor signaling pathway,M100,1,0
0,1,0,0,-2.5,0,GO:0015914,phospholipid transport,M010,1,0
1,0,0,-2.1,0,0,GO:0046627,negative regulation of insulin receptor signaling pathway,M100,1,0
0,0,1,0,0,-2.7,R-HSA-975577,N-Glycan antennae elongation,M001,1,0
0,1,0,0,-2.2,0,GO:0045683,negative regulation of epidermis development,M010,1,0
0,0,1,0,0,-2.7,WP2853,Endoderm differentiation,M001,1,0
0,1,0,0,-2.3,0,GO:0002704,negative regulation of leukocyte mediated immunity,M010,1,0
0,0,1,0,0,-3,hsa05321,Inflammatory bowel disease,M001,1,0
1,0,0,-2.7,0,0,GO:0042474,middle ear morphogenesis,M100,1,0
0,0,1,0,0,-3.4,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",M001,1,0
0,0,1,0,0,-3.7,GO:0001892,embryonic placenta development,M001,1,0
0,0,1,0,0,-2.1,GO:0030324,lung development,M001,1,0
0,0,1,0,0,-3.3,hsa05221,Acute myeloid leukemia,M001,1,0
0,0,1,0,0,-3.1,GO:0048341,paraxial mesoderm formation,M001,1,0
0,0,1,0,0,-2,GO:2001054,negative regulation of mesenchymal cell apoptotic process,M001,1,0
0,1,0,0,-2,0,GO:0060761,negative regulation of response to cytokine stimulus,M010,1,0
0,1,0,0,-2.3,0,GO:0048048,embryonic eye morphogenesis,M010,1,0
1,0,0,-2.7,0,0,GO:0086026,atrial cardiac muscle cell to AV node cell signaling,M100,1,0
1,0,0,-2.2,0,0,GO:0006023,aminoglycan biosynthetic process,M100,1,0
1,0,0,-3.6,0,0,R-HSA-9834899,Specification of the neural plate border,M100,1,0
0,0,1,0,0,-2.5,WP3995,Prion disease pathway,M001,1,0
1,0,0,-2,0,0,GO:0060544,regulation of necroptotic process,M100,1,0
0,0,1,0,0,-2.1,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",M001,1,0
1,0,0,-3.7,0,0,GO:0060136,embryonic process involved in female pregnancy,M100,1,0
0,0,1,0,0,-2.7,GO:0006991,response to sterol depletion,M001,1,0
0,1,0,0,-2.3,0,GO:0030225,macrophage differentiation,M010,1,0
1,0,0,-2.4,0,0,GO:0042473,outer ear morphogenesis,M100,1,0
0,0,1,0,0,-2.4,WP4300,Extracellular vesicles in the crosstalk of cardiac cells,M001,1,0
0,0,1,0,0,-2.2,GO:0032103,positive regulation of response to external stimulus,M001,1,0
0,0,1,0,0,-2.1,hsa05224,Breast cancer,M001,1,0
0,0,1,0,0,-2.4,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,M001,1,0
0,1,0,0,-2.9,0,GO:0071772,response to BMP,M010,1,0
1,0,0,-2.2,0,0,GO:0003264,regulation of cardioblast proliferation,M100,1,0
0,0,1,0,0,-2.4,GO:0043383,negative T cell selection,M001,1,0
0,0,1,0,0,-2.2,GO:0042098,T cell proliferation,M001,1,0
0,0,1,0,0,-3.7,GO:0035050,embryonic heart tube development,M001,1,0
0,0,1,0,0,-2,GO:0031929,TOR signaling,M001,1,0
0,0,1,0,0,-2.5,M223,PID BETA CATENIN NUC PATHWAY,M001,1,0
1,0,0,-2.6,0,0,GO:0010595,positive regulation of endothelial cell migration,M100,1,0
0,0,1,0,0,-3.3,GO:0001947,heart looping,M001,1,0
0,0,1,0,0,-2.4,M151,PID AR TF PATHWAY,M001,1,0
0,0,1,0,0,-2.7,GO:0050679,positive regulation of epithelial cell proliferation,M001,1,0
0,0,1,0,0,-2.6,M33,PID GLYPICAN 1PATHWAY,M001,1,0
0,1,0,0,-2,0,GO:0060074,synapse maturation,M010,1,0
0,0,1,0,0,-2.2,R-HSA-114604,GPVI-mediated activation cascade,M001,1,0
1,0,0,-2.5,0,0,GO:2000136,regulation of cell proliferation involved in heart morphogenesis,M100,1,0
1,0,0,-2.4,0,0,GO:0014904,myotube cell development,M100,1,0
0,0,1,0,0,-3.6,M279,PID RB 1PATHWAY,M001,1,0
0,0,1,0,0,-3.3,R-HSA-201681,TCF dependent signaling in response to WNT,M001,1,0
0,1,0,0,-2.2,0,R-HSA-5621575,CD209 (DC-SIGN) signaling,M010,1,0
0,0,1,0,0,-2.9,GO:0046640,regulation of alpha-beta T cell proliferation,M001,1,0
0,0,1,0,0,-2.8,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M001,1,0
0,0,1,0,0,-2.5,R-HSA-9664417,Leishmania phagocytosis,M001,1,0
0,0,1,0,0,-2.6,GO:0031349,positive regulation of defense response,M001,1,0
0,1,0,0,-2.9,0,M1315,SIG PIP3 SIGNALING IN B LYMPHOCYTES,M010,1,0
0,0,1,0,0,-2.4,GO:0010885,regulation of cholesterol storage,M001,1,0
0,0,1,0,0,-2.2,WP1591,Heart development,M001,1,0
0,0,1,0,0,-5.2,GO:0045444,fat cell differentiation,M001,1,0
1,0,0,-4.1,0,0,WP2112,IL 17 signaling pathway,M100,1,0
0,0,1,0,0,-2.4,WP3972,PDGFR beta pathway,M001,1,0
0,0,1,0,0,-3.3,GO:0045661,regulation of myoblast differentiation,M001,1,0
0,1,0,0,-2.3,0,hsa05133,Pertussis,M010,1,0
0,1,0,0,-4.1,0,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,M010,1,0
0,1,0,0,-3.8,0,GO:0022604,regulation of cell morphogenesis,M010,1,0
1,0,0,-2,0,0,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,M100,1,0
0,1,0,0,-2.2,0,GO:0055003,cardiac myofibril assembly,M010,1,0
0,0,1,0,0,-2.6,WP98,Prostaglandin synthesis and regulation,M001,1,0
0,0,1,0,0,-2.2,GO:0019370,leukotriene biosynthetic process,M001,1,0
0,0,1,0,0,-2.1,GO:0006636,unsaturated fatty acid biosynthetic process,M001,1,0
1,0,0,-3,0,0,GO:0034330,cell junction organization,M100,1,0
0,1,0,0,-2.4,0,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,M010,1,0
0,0,1,0,0,-4.1,GO:0045586,regulation of gamma-delta T cell differentiation,M001,1,0
0,1,0,0,-2,0,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,M010,1,0
0,0,1,0,0,-3.5,GO:0070661,leukocyte proliferation,M001,1,0
0,0,1,0,0,-2.5,R-HSA-9825892,Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,M001,1,0
0,0,1,0,0,-2.3,GO:0023061,signal release,M001,1,0
0,0,1,0,0,-5.6,GO:0072089,stem cell proliferation,M001,1,0
0,1,0,0,-2.3,0,GO:1901796,regulation of signal transduction by p53 class mediator,M010,1,0
0,0,1,0,0,-2.6,GO:0021885,forebrain cell migration,M001,1,0
0,0,1,0,0,-2,GO:0021889,olfactory bulb interneuron differentiation,M001,1,0
0,0,1,0,0,-2.4,GO:0002071,glandular epithelial cell maturation,M001,1,0
0,0,1,0,0,-2,WP4657,22q11 2 copy number variation syndrome,M001,1,0
0,0,1,0,0,-2.6,R-HSA-195721,Signaling by WNT,M001,1,0
0,0,1,0,0,-2.1,WP2876,Pregnane X receptor pathway,M001,1,0
0,0,1,0,0,-2.4,GO:0071277,cellular response to calcium ion,M001,1,0
0,0,1,0,0,-3,GO:0071559,response to transforming growth factor beta,M001,1,0
1,0,0,-3.2,0,0,hsa05208,Chemical carcinogenesis - reactive oxygen species,M100,1,0
0,1,0,0,-2.2,0,GO:0001562,response to protozoan,M010,1,0
0,0,1,0,0,-3.2,GO:0002053,positive regulation of mesenchymal cell proliferation,M001,1,0
0,0,1,0,0,-3.1,GO:0021814,cell motility involved in cerebral cortex radial glia guided migration,M001,1,0
1,0,0,-4.3,0,0,R-HSA-112316,Neuronal System,M100,1,0
1,0,0,-2.4,0,0,GO:0021783,preganglionic parasympathetic fiber development,M100,1,0
1,0,0,-2.4,0,0,GO:0003266,regulation of secondary heart field cardioblast proliferation,M100,1,0
0,0,1,0,0,-3.2,GO:0061371,determination of heart left/right asymmetry,M001,1,0
0,0,1,0,0,-3.2,GO:0061035,regulation of cartilage development,M001,1,0
0,0,1,0,0,-2.4,GO:0034391,regulation of smooth muscle cell apoptotic process,M001,1,0
0,0,1,0,0,-2.2,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,M001,1,0
0,1,0,0,-3.2,0,WP4585,Cancer immunotherapy by PD 1 blockade,M010,1,0
0,0,1,0,0,-2.8,GO:0022029,telencephalon cell migration,M001,1,0
0,1,0,0,-2.9,0,R-HSA-202733,Cell surface interactions at the vascular wall,M010,1,0
0,1,0,0,-2.9,0,WP5174,Ulcerative colitis signaling,M010,1,0
0,0,1,0,0,-2.7,GO:0002576,platelet degranulation,M001,1,0
1,0,0,-2.9,0,0,WP3414,Initiation of transcription and translation elongation at the HIV 1 LTR,M100,1,0
0,1,0,0,-2.4,0,M63,PID AVB3 OPN PATHWAY,M010,1,0
0,0,1,0,0,-3.1,GO:0048663,neuron fate commitment,M001,1,0
0,1,0,0,-2.1,0,M54,PID IL12 2PATHWAY,M010,1,0
0,0,1,0,0,-2.5,R-HSA-9664422,FCGR3A-mediated phagocytosis,M001,1,0
1,0,0,-2.5,0,0,R-HSA-451326,Activation of kainate receptors upon glutamate binding,M100,1,0
0,0,1,0,0,-2.9,GO:0060070,canonical Wnt signaling pathway,M001,1,0
1,0,0,-2.4,0,0,GO:0035418,protein localization to synapse,M100,1,0
0,0,1,0,0,-3.1,GO:0048864,stem cell development,M001,1,0
1,0,0,-2.8,0,0,GO:0032722,positive regulation of chemokine production,M100,1,0
0,0,1,0,0,-2.4,GO:0030838,positive regulation of actin filament polymerization,M001,1,0
0,0,1,0,0,-2.1,GO:0032673,regulation of interleukin-4 production,M001,1,0
1,0,0,-2.1,0,0,GO:0051602,response to electrical stimulus,M100,1,0
0,1,0,0,-2.6,0,GO:0045860,positive regulation of protein kinase activity,M010,1,0
0,1,0,0,-2,0,GO:0032409,regulation of transporter activity,M010,1,0
0,0,1,0,0,-3.2,hsa05210,Colorectal cancer,M001,1,0
0,1,0,0,-2.2,0,GO:0035584,calcium-mediated signaling using intracellular calcium source,M010,1,0
0,0,1,0,0,-3,R-HSA-2172127,DAP12 interactions,M001,1,0
0,0,1,0,0,-2.7,GO:0021846,cell proliferation in forebrain,M001,1,0
0,0,1,0,0,-2.2,GO:0006690,icosanoid metabolic process,M001,1,0
0,0,1,0,0,-2.7,GO:0042492,gamma-delta T cell differentiation,M001,1,0
0,0,1,0,0,-4.9,GO:0002063,chondrocyte development,M001,1,0
0,0,1,0,0,-2.3,hsa04148,Efferocytosis,M001,1,0
0,0,1,0,0,-2.7,GO:0014032,neural crest cell development,M001,1,0
0,0,1,0,0,-2.2,hsa05216,Thyroid cancer,M001,1,0
0,0,1,0,0,-3.3,GO:0033077,T cell differentiation in thymus,M001,1,0
1,0,0,-2.2,0,0,WP4874,CAMKK2 pathway,M100,1,0
0,0,1,0,0,-3.1,GO:0071715,icosanoid transport,M001,1,0
0,0,1,0,0,-2.9,GO:0002253,activation of immune response,M001,1,0
0,1,0,0,-2.4,0,GO:0002887,negative regulation of myeloid leukocyte mediated immunity,M010,1,0
0,0,1,0,0,-2.2,GO:0090335,regulation of brown fat cell differentiation,M001,1,0
0,1,0,0,-2.2,0,GO:0051051,negative regulation of transport,M010,1,0
0,1,0,0,-2,0,GO:1902992,negative regulation of amyloid precursor protein catabolic process,M010,1,0
0,0,1,0,0,-3.5,GO:0042100,B cell proliferation,M001,1,0
0,1,0,0,-2.7,0,GO:1903829,positive regulation of protein localization,M010,1,0
0,1,0,0,-2.5,0,WP289,Myometrial relaxation and contraction pathways,M010,1,0
0,1,0,0,-2,0,WP3877,MYD88 distinct input output pathway,M010,1,0
0,0,1,0,0,-2.6,GO:0003231,cardiac ventricle development,M001,1,0
1,0,0,-2.5,0,0,hsa04933,AGE-RAGE signaling pathway in diabetic complications,M100,1,0
1,0,0,-2.4,0,0,GO:0048752,semicircular canal morphogenesis,M100,1,0
1,0,0,-2.7,0,0,WP2324,AGE RAGE pathway,M100,1,0
0,1,0,0,-2.6,0,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,M010,1,0
0,0,1,0,0,-2,GO:0001516,prostaglandin biosynthetic process,M001,1,0
0,0,1,0,0,-2.1,GO:0062013,positive regulation of small molecule metabolic process,M001,1,0
1,0,0,-2,0,0,GO:1900017,positive regulation of cytokine production involved in inflammatory response,M100,1,0
0,1,0,0,-2.2,0,GO:0043549,regulation of kinase activity,M010,1,0
0,0,1,0,0,-5.4,GO:0030855,epithelial cell differentiation,M001,1,0
0,0,1,0,0,-3.1,CORUM:2536,PLC-gamma-2-SLP-76-Lyn-Grb2 complex,M001,1,0
1,0,0,-2,0,0,GO:0001710,mesodermal cell fate commitment,M100,1,0
0,0,1,0,0,-2.9,R-HSA-9758941,Gastrulation,M001,1,0
0,0,1,0,0,-2.2,R-HSA-9830674,Formation of the ureteric bud,M001,1,0
0,0,1,0,0,-4.5,R-HSA-912631,Regulation of signaling by CBL,M001,1,0
0,1,0,0,-2.7,0,hsa05134,Legionellosis,M010,1,0
0,0,1,0,0,-3.7,GO:0042692,muscle cell differentiation,M001,1,0
0,0,1,0,0,-2.6,GO:0022612,gland morphogenesis,M001,1,0
0,1,0,0,-2.7,0,WP2795,Cardiac hypertrophic response,M010,1,0
0,0,1,0,0,-2.5,GO:0006029,proteoglycan metabolic process,M001,1,0
0,0,1,0,0,-2.9,GO:0071498,cellular response to fluid shear stress,M001,1,0
0,0,1,0,0,-3.4,GO:0003416,endochondral bone growth,M001,1,0
0,0,1,0,0,-3.8,GO:0048821,erythrocyte development,M001,1,0
1,0,0,-3.7,0,0,GO:0007215,glutamate receptor signaling pathway,M100,1,0
0,0,1,0,0,-2.6,GO:0072009,nephron epithelium development,M001,1,0
1,0,0,-2.8,0,0,GO:0010634,positive regulation of epithelial cell migration,M100,1,0
0,0,1,0,0,-2.2,GO:0001823,mesonephros development,M001,1,0
0,1,0,0,-2.5,0,GO:0031401,positive regulation of protein modification process,M010,1,0
0,1,0,0,-2.4,0,GO:0002377,immunoglobulin production,M010,1,0
1,0,0,-2.2,0,0,WP3878,ATM signaling in development and disease,M100,1,0
0,1,0,0,-3.7,0,GO:0045185,maintenance of protein location,M010,1,0
1,0,0,-3,0,0,GO:0003013,circulatory system process,M100,1,0
1,0,0,-2.2,0,0,GO:0048538,thymus development,M100,1,0
0,0,1,0,0,-2,GO:0001936,regulation of endothelial cell proliferation,M001,1,0
0,0,1,0,0,-2.8,R-HSA-383280,Nuclear Receptor transcription pathway,M001,1,0
0,0,1,0,0,-3.1,GO:0021815,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,M001,1,0
0,0,1,0,0,-2,WP2858,Ectoderm differentiation,M001,1,0
0,1,0,0,-2.3,0,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),M010,1,0
1,0,0,-2.6,0,0,M113,PID NFAT 3PATHWAY,M100,1,0
0,1,0,0,-2.2,0,GO:0150079,negative regulation of neuroinflammatory response,M010,1,0
0,0,1,0,0,-2.5,GO:0072073,kidney epithelium development,M001,1,0
0,0,1,0,0,-2.7,GO:0030031,cell projection assembly,M001,1,0
1,0,0,-2.5,0,0,GO:0032642,regulation of chemokine production,M100,1,0
1,0,0,-2.5,0,0,GO:0035136,forelimb morphogenesis,M100,1,0
0,0,1,0,0,-3,hsa04611,Platelet activation,M001,1,0
1,0,0,-2,0,0,WP4148,Splicing factor NOVA regulated synaptic proteins,M100,1,0
0,1,0,0,-3.1,0,GO:0010911,regulation of isomerase activity,M010,1,0
0,0,1,0,0,-2.1,GO:0010876,lipid localization,M001,1,0
0,0,1,0,0,-4.4,GO:0048589,developmental growth,M001,1,0
1,0,0,-2.2,0,0,GO:0006024,glycosaminoglycan biosynthetic process,M100,1,0
0,0,1,0,0,-4.5,GO:0045582,positive regulation of T cell differentiation,M001,1,0
0,1,0,0,-2.5,0,GO:0045937,positive regulation of phosphate metabolic process,M010,1,0
0,0,1,0,0,-3.8,GO:0043030,regulation of macrophage activation,M001,1,0
0,0,1,0,0,-4.8,GO:0030851,granulocyte differentiation,M001,1,0
1,0,0,-2.8,0,0,GO:0007416,synapse assembly,M100,1,0
0,0,1,0,0,-4,WP2877,Vitamin D receptor pathway,M001,1,0
1,0,0,-2.5,0,0,GO:1990806,ligand-gated ion channel signaling pathway,M100,1,0
0,1,0,0,-2.7,0,GO:0021895,cerebral cortex neuron differentiation,M010,1,0
0,0,1,0,0,-2.5,GO:0060351,cartilage development involved in endochondral bone morphogenesis,M001,1,0
0,1,0,0,-2.5,0,WP2203,Thymic stromal lymphopoietin TSLP signaling pathway,M010,1,0
0,0,1,0,0,-2.1,WP299,Nuclear receptors in lipid metabolism and toxicity,M001,1,0
1,0,0,-3.4,0,0,GO:0060216,definitive hemopoiesis,M100,1,0
0,1,0,0,-2.9,0,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,M010,1,0
1,0,0,-2,0,0,GO:0051412,response to corticosterone,M100,1,0
0,0,1,0,0,-2.9,GO:0046633,alpha-beta T cell proliferation,M001,1,0
1,0,0,-3.1,0,0,R-HSA-451306,Ionotropic activity of kainate receptors,M100,1,0
0,0,1,0,0,-2.2,GO:0090630,activation of GTPase activity,M001,1,0
0,1,0,0,-2,0,GO:0045064,T-helper 2 cell differentiation,M010,1,0
0,0,1,0,0,-2.5,GO:0007219,Notch signaling pathway,M001,1,0
0,0,1,0,0,-3.8,GO:0035265,organ growth,M001,1,0
1,0,0,-2.4,0,0,GO:0043584,nose development,M100,1,0
1,0,0,-2.1,0,0,GO:0070482,response to oxygen levels,M100,1,0
0,0,1,0,0,-2,GO:0030323,respiratory tube development,M001,1,0
1,0,0,-2.1,0,0,GO:0061008,hepaticobiliary system development,M100,1,0
0,1,0,0,-2.9,0,GO:0050767,regulation of neurogenesis,M010,1,0
0,1,0,0,-2.7,0,CORUM:642,CtBP complex,M010,1,0
0,0,1,0,0,-2.6,GO:0002286,T cell activation involved in immune response,M001,1,0
0,1,0,0,-2.2,0,GO:0051235,maintenance of location,M010,1,0
1,0,0,-2.9,0,0,GO:2000107,negative regulation of leukocyte apoptotic process,M100,1,0
0,1,0,0,-2.4,0,GO:0001934,positive regulation of protein phosphorylation,M010,1,0
0,0,1,0,0,-3.7,GO:0046637,regulation of alpha-beta T cell differentiation,M001,1,0
0,0,1,0,0,-3.1,GO:0006491,N-glycan processing,M001,1,0
0,0,1,0,0,-2.2,GO:1903146,regulation of autophagy of mitochondrion,M001,1,0
0,1,0,0,-2.4,0,WP2873,Aryl hydrocarbon receptor pathway,M010,1,0
0,0,1,0,0,-3.2,GO:0071241,cellular response to inorganic substance,M001,1,0
1,0,0,-2,0,0,GO:1901223,negative regulation of non-canonical NF-kappaB signal transduction,M100,1,0
0,0,1,0,0,-2,GO:0046457,prostanoid biosynthetic process,M001,1,0
0,1,0,0,-2.4,0,GO:0061900,glial cell activation,M010,1,0
1,0,0,-2,0,0,GO:0008088,axo-dendritic transport,M100,1,0
0,1,0,0,-2,0,GO:1902430,negative regulation of amyloid-beta formation,M010,1,0
0,0,1,0,0,-2.7,GO:0010883,regulation of lipid storage,M001,1,0
1,0,0,-2.7,0,0,WP28,Selenium metabolism and selenoproteins,M100,1,0
0,1,0,0,-2.2,0,GO:0045190,isotype switching,M010,1,0
0,0,1,0,0,-2.4,GO:0060333,type II interferon-mediated signaling pathway,M001,1,0
0,0,1,0,0,-2.5,GO:0051250,negative regulation of lymphocyte activation,M001,1,0
0,0,1,0,0,-2.6,GO:0001649,osteoblast differentiation,M001,1,0
0,1,0,0,-3.4,0,GO:0051651,maintenance of location in cell,M010,1,0
0,1,0,0,-2.4,0,GO:0002440,production of molecular mediator of immune response,M010,1,0
0,0,1,0,0,-2.1,GO:0071248,cellular response to metal ion,M001,1,0
0,0,1,0,0,-2.2,GO:0048332,mesoderm morphogenesis,M001,1,0
0,1,0,0,-2.1,0,GO:0034764,positive regulation of transmembrane transport,M010,1,0
0,1,0,0,-2.7,0,R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),M010,1,0
0,0,1,0,0,-2.7,GO:0007369,gastrulation,M001,1,0
